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Chapter 1
General introduction
8 Chapter 1
Rheumatoid arthritis
Rheumatoid Arthritis (RA) is a chronic inflammatory disease, characterized by 
synovitis of multiple joints, resulting in pain, disability, and progressive joint de-
struction (1). Patients with RA have a higher mortality rate compared to the gen-
eral population (2). RA affects about 0.5-1% of the population world-wide and 
occurs more frequent in woman (1, 3). In the Netherlands about 116.000 people 
were diagnosed with RA in 2011, of which 74.000 were female and 42.000 were 
male (4). Although the disease can occur at any age, its incidence increases with 
age and most cases have an onset between 40 and 70 years (5). 
The precise etiology of RA is unknown. The pathogenesis is multifactorial, 
and both genetic factors, environmental factors and immunological factors play a 
role (5-7). So far there is no therapy available to cure the disease. Pharmacolog-
ical treatment with so called Disease Modifying Antirheumatic Drugs (DMARD), 
such as methotrexate, and Biological Response Modifiers, such as anti-tumor 
necrosis factor (anti-TNF), is available to reduce and control the disease activity, 
and to prevent the destruction of synovial joints. Non-pharmacological treat-
ments, such as physical therapy and psychological counseling, are aimed to con-
trol symptoms and improve daily functioning in patients with RA. 
Fatigue as a symptom 
Symptoms that are frequently reported by patients with RA are joint pain, joint 
stiffness, impairment in daily functioning, and fatigue (8-11). Pain as well as 
fatigue were mentioned by patients with RA as being the two most disturbing 
symptoms of the disease (12-15). It seems that since the disease activity in RA is 
better controlled due to more effective treatment options, feeling less fatigued 
is more important for patients with RA than improving other outcomes such as 
joint swelling and stiffness (14). 
The importance and recognition of fatigue as patient relevant symptom has 
grown. Nevertheless, fatigue is not yet included in the ACR core set variables 
used to assess the efficacy of potential DMARDs in trials (16). However, the pa-
tient perspective workshop at OMERACT 8 (an international group of experts on 
Outcome Measures in Rheumatology Clinical Trials) endorsed the proposal that, 
in addition to the “core set” of outcome measures currently in widespread use, 
fatigue should be measured in future studies of RA whenever possible (17). The 
workshop concluded that fatigue is a symptom that is important to patients, is 
commonly reported by patients, is often severe, is responsive to some interven-
tions, can be measured by several current instruments, and provides information 
additional to that commonly obtained from currently used outcomes (17). Un-
fortunately, fatigue in RA is not mild and it tends to stay. Already in 2007 Rep-
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ping-Wuts showed that in RA fatigue is often severe as well as persistent; 40% of 
the patients with RA were severely fatigued at baseline and after one year (18). 
Other longitudinal studies did also show that fatigue is relative stable over time, 
although fatigue was only measured at baseline and at 12 months, not in the 
intermediate period (19, 20). 
Fatigue is not a negative symptom per se. But, patients with RA experience 
fatigue differently than healthy people do experience fatigue (10, 21). The kind 
of fatigue healthy people experience may for example result from strenuous 
physical exercising or a busy week. This is normal fatigue and resting brings re-
lief. However this is not the case in patients with RA where patients express their 
fatigue as exhaustive, debilitating and restricting daily functioning (10, 21-23). 
Moreover, fatigue causes changes in cognitive ability and overall activity pattern 
and an increased need for sleep and rest causes an imbalance in daily life (23). 
Fatigue in RA is variable in duration and intensity and not occurring at regular 
times or same days of the week (21). In addition, Repping-Wuts showed that 
fatigue has a greater impact on daily life than pain has (21). However, patients 
with RA seldom mentioned fatigue explicitly to their professional healthcare pro-
viders, assuming that it cannot be treated and that they must manage it alone 
(21). Although it appears that fatigue is severe and prevalent in RA, in the gen-
eral population fatigue appears not to be uncommon, at least in the Western 
society. Whether fatigue in RA indeed is more severe than in the general pop-
ulation is not clear. In RA fatigue, many factors may play a role, however it is 
unknown which factors are either cause or consequence of fatigue in RA. Differ-
ent cross-sectional studies have been performed when investigating associations 
between different factors and fatigue in RA. A causal relationship between these 
variables and fatigue in RA is difficult to establish, and needs testing in longitudi-
nal observational studies or RCT’s with interventions for these factors. However, 
to increase evidence how these factors together may contribute to fatigue in 
RA, a multidimensional ‘path analysis’ model could be devised and this will give 
knowledge which factors should be treated to reduce fatigue in RA. 
Treatment of fatigue 
Currently there is no clearly effective treatment strategy available to treat fatigue 
in RA. The lack of knowledge of effective interventions has led to fatigue being 
neglected during patient-physician contacts (24, 25). The presence of fatigue in 
patients with RA who are reasonably well treated for their RA, suggests that 
DMARD and biological treatment may not be sufficient to treat RA fatigue. That 
is to say, there is some evidence that in RA, pharmacological treatments indeed 
reduce fatigue, together with pain and disease activity, but generally speaking, 
fatigue is unresolved. The largest reductions in fatigue occurred during the first 
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6 months of treatment and effect sizes were modest (26-29). In a quasi-exper-
imental study of patients with established RA, it appeared that there was no 
difference in persistent severe fatigue between users of DMARDs and anti-TNF 
users (30). 
In patients with other chronic disorders in which fatigue is a long-term symp-
tom, such as cancer survivors and patients with the chronic fatigue syndrome 
(CFS), cognitive behavioural therapy (CBT) is effective in treating fatigue (31-33). 
In patients with CFS, besides CBT, graded exercise therapy (GET) also is effective 
in treating fatigue (34, 35). CFS is notoriously difficult to treat, and it appears 
that CBT and GET level are the only effective interventions. Therefore, there is 
a good reason to regard CBT and increasing physical activity as two likely candi-
dates to treat fatigue in RA. 
Physical activity as a treatment option for fatigue 
RA affects one’s movement apparatus, and consequently may cause disability 
and impair one’s level of physical activity. That patients with RA experience ex-
cess disability, beyond the influence of age and gender is already clear. Indeed, 
decreased levels of self-reported physical activity have been reported among 
patients with RA (36-38), however physical activity in RA has not been measured 
objectively. 
It is assumed that physical activity is decreased in patients with RA as a con-
sequence of fatigue, joint pain, restricted mobility, reduced muscle mass, less 
strength and aerobic capacity (39-41). This also implies that reduced physical 
activity can be a cause as well as a consequence of fatigue in RA. Factors most 
strongly related to inactivity in RA were reduced self-efficacy for exercise (42), 
fear avoidance (43), lack of strong motivation for physical activity and lack of 
strong beliefs related to physical activity (44, 45). In turn, physical inactivity in 
RA may lead to more severe fatigue, lower functional capacity, less quality of life 
and further progression of the disease (46-48). The persistence of fatigue may be 
related to the presence of some, roughly drawn, vicious circle (Figure 1). 
Accordingly, it can be hypothesized that a decrease in physical activity is asso-
ciated with a higher level of fatigue which leads to more mood disturbance and 
less sense of control associated with a further decrease in physical activity. In pa-
tients with other chronic conditions such as CFS, Sjögren’s syndrome, cancer and 
Parkinson’s disease, a higher level of fatigue seems associated with a lower level 
of physical activity (49-52). However, the relation between the level of physical 
activity and fatigue in RA is unknown yet. Increasing physical activity in patients 
with RA, could break this vicious circle and could have positive effects on fatigue 
with as consequence a better mood and more sense of control.
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Figure 1. Hypothetical vicious circle
Aim of this thesis
The aim of this thesis is to gain more insight into factors associated with fatigue 
in RA, especially the association between physical activity and fatigue. Clarifying 
the association between the level of physical activity and the level of fatigue may 
provide new knowledge if increasing the level of physical activity could break the 
vicious circle, fatigued patients with RA find themselves into. 
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Outline of this thesis
In chapter 1 an introduction to the problem of fatigue in RA is given and our 
hypothesis about the relationship between physical activity and fatigue is dis-
cussed. In chapter 2 the course of fatigue and pain in patients with RA in a peri-
od of one year was investigated. The objective of this longitudinal study was to 
investigate whether changes in pain precede changes in fatigue, or vice versa, 
or whether pain and fatigue fluctuate together in time. In chapter 3 it was in-
vestigated whether objectively measured activity levels and activity patterns are 
associated with fatigue levels in patients with RA, and whether pain, disability, 
coping, and/or cognition are associated with—or influence—the level of activity 
among patients with RA. The level of daily activity in patients with RA was inves-
tigated objectively during 14 consecutive days. In chapter 4, we compared the 
level of physical activity and the level of fatigue between patients with RA and 
the general Dutch population and investigated whether self-reported physical 
activity in RA depends on age, gender, BMI, and disease duration. In addition, it 
was described how many patients with RA are engaged in sports and in which 
sport activities. In chapter 5, a multidimensional model of factors that determine 
fatigue severity in RA was developed. Besides pain and physical functioning, oth-
er important factors related to fatigue in RA known from previous research were 
included, which are psychosocial factors, mood disturbance and sleep quality. 
Developing such a model of fatigue might facilitate which factors are meaningful 
targets for the treatment of fatigue in RA. In chapter 6, we performed a me-
ta-analysis to summarize the limited evidence and estimated the mean effect of 
aerobic land-based exercise programs on fatigue in RA. In chapter 7 we discuss 
our findings and recommendations for further research will be given. Chapter 8 
provides an overall summary. 
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Abstract
Objective 
Fatigue and pain are important symptoms for patients with Rheumatoid Arthritis 
(RA), but their temporal association is unknown. Therefore, the objective of this 
study was to investigate the longitudinal relation between fatigue and pain in 
patients with RA using time-lag models. 
Methods 
Consecutive RA outpatients (N=228) were enrolled for this 1-year study. Fatigue 
was assessed monthly with the Checklist Individual Strength (CIS; range 8-56) 
and pain was assessed monthly with the Bodily Pain subscale (inverted, range 
0-100) of the Short Form 36. The association between monthly changes in fa-
tigue and pain was analyzed using longitudinal regression (mixed models), using 
the same months and with a 1-month time-lag. 
Results 
A total of 198 patients were included in the analyses. At baseline, the mean ± 
SD pain score was 35.23 ± 19.82 and the mean ± SD CIS-fatigue score was 31.0 
± 12.4. Severe fatigue at baseline (CIS score ≥35) was present in 42% of the pa-
tients. The mean ± SD patient-averaged CIS-fatigue score over 1 year was 30.9 ± 
6.0 and the mean ± SD patient-averaged pain score over 1 year was 36.4 ± 18.3. 
The longitudinal regression analysis showed a significant positive relationship 
between fatigue and pain during the same month (β=2.04, 95% confidence in-
terval 1.82, 2.27). The models using a time lag showed no significant association 
between changes in pain and changes in fatigue. 
Conclusion 
In established RA, pain and fatigue show monthly fluctuations that are synchro-
nous rather than showing a temporal relation with a time-lag; within this time 
frame, the results do not indicate that one precedes the other. 
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Introduction
Rheumatoid Arthritis (RA) is a chronic autoimmune disorder causing inflamma-
tion, stiffness and pain in the joints (1). In RA, fatigue is a frequently occurring 
and patient-relevant complaint which frequently is experienced as debilitating 
and restricting daily functioning (2). In cross-sectional studies, it is found that at 
least 40% of the RA patients is severely fatigued (3, 4). Pain and fatigue are the 
symptoms mentioned by RA patients as the most disturbing symptoms of the 
disease (5-7). 
RA fatigue can be influenced by numerous factors, such as inflammation, 
pain, disability and psychosocial factors (mood, beliefs, behavior) (8-10). Al-
though chronic inflammation might cause fatigue, in RA it has been shown that 
pain, rather than inflammation, is associated with fatigue severity (4, 7-9, 11-15). 
Fatigue and pain often co-occur, and there are previous mainly cross-sectional 
studies showing that more fatigue is strongly associated with more pain (4, 8, 9, 
16). Few studies have measured fatigue over 1 year in RA (3, 15). It was shown 
that severe fatigue was experienced in 50% of the RA patients, both at baseline 
and at 12-month follow-up (3). Also in RA, a higher pain score at baseline predict-
ed worse fatigue 1 year later (15).
The association of pain and fatigue could be synchronous or with a time lag, 
meaning that a change in pain could be associated with a change in fatigue at 
the same time (synchronous), or that a change in pain may precede a change in 
fatigue or a change in fatigue may precede a change in pain.
Temporal associations between pain and fatigue in RA might be day to day 
(e.g. pain today associated with fatigue tomorrow) or month to month (17-19). 
Currently, it is unclear whether a change in pain precedes a change in fatigue or 
whether a change in fatigue precedes a change in pain. It could be hypothesized 
both that pain can lead to fatigue because of the energy consumed by prolonged 
pain suppression and the need to deal with pain, but also that fatigue can lead 
to pain because of being less able to suppress and deal with pain (20, 21). There-
fore, the question is whether increased levels of pain are followed by an increase 
in fatigue or whether it is vice versa: i.e., increased levels of fatigue are followed 
by an increase in pain. It also may be that changes in fatigue and pain tend to 
fluctuate together and do not show such a temporal association. Therefore, the 
objective of this study was to investigate the longitudinal relation between fa-
tigue and pain in patients with RA using time-lag models. 
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Patients and methods
Design
This is a prospective cohort study of 1 year with monthly repeated measures 
of both fatigue and pain in consecutive patients with established RA. Over the 
course of 2 weeks, daily assessments of pain and fatigue were performed. Ap-
proval for this study was obtained from the ethical committee (CMO Arnhem-Ni-
jmegen, The Netherlands).
Patients
A total of 230 RA patients attending the outpatient clinic of the Radboud Univer-
sity Nijmegen Medical Centre were approached between June 2006 and October 
2007 to participate in this study. Patients were informed in writing and orally 
by their rheumatologist or a nurse specialist and invited to participate in the 
study.  
Inclusion criteria consisted of a diagnosis of RA according to the 1987 ACR
classification criteria (22), being age 18–75 years, and being able to read and 
write in the Dutch language. Study participation was allowed with comorbidities 
such as secondary Sjögren’s syndrome, regulated thyroid disease (values of free 
T4 of minimally 8 pmoles/liter and thyroid stimulating hormone, maximum 1.0 
units/liter), regulated diabetes mellitus (normalized glucose values between 2.5 
and 3.7 mmoles/liter in urine and between 4.0 and 5.6 mmoles/liter in blood and 
glycosylated hemoglobin <8.0%), mild nonrestrictive chronic obstructive pulmo-
nary disease, and successfully treated not metastasized basal cell carcinoma or 
squamous cell carcinoma in the skin in medical history. Patients were excluded 
from study participation if they had a second rheumatic disease (except for sec-
ondary Sjögren’s syndrome), a history of malignancies or other comorbidities 
associated with chronic fatigue, a current diagnosis of depression, or current 
psychological or psychiatric treatment.
Data collection
Patient characteristics (sex and age), disease characteristics (disease duration 
and rheumatoid factor), and medication use were collected at inclusion (base-
line) by research nurses. A blood sample was taken (for erythrocyte sedimenta-
tion rate, C-reactive protein level, and hemoglobin level) and disease activity was 
assessed by the rheumatologist or a research nurse using the Disease Activity 
Score in 28 joints (DAS28). Restrictions of daily functioning were assessed using 
the Health Assessment Questionnaire (HAQ) disability index (23). 
Fatigue and pain were self-assessed every month for 12 consecutive months. 
Fatigue severity was measured using the fatigue severity subscale of the 20-item 
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Checklist Individual Strength (CIS20), which also contains subscales of physical 
activity, motivation, and concentration (24). The CIS fatigue consists of 8 items 
on fatigue symptom severity regarding the last 2 weeks and all items are scored 
on a 7-point Likert scale (range 8–56). Higher scores on the CIS fatigue indicate 
a higher level of fatigue experienced; a score of < 27 is considered normal and a 
score of ≥ 35 indicates severe fatigue (24). The CIS20 has proven to be a reliable 
and valid instrument in numerous conditions and was also used in RA (24,25). 
Pain was assessed with the bodily pain subscale of the Short Form 36 health
survey (SF-36), which asks about pain experienced in the last 2 weeks (26). The 
SF-36 bodily pain subscale consists of 2 items, one regarding pain level and one 
asking about the impact of pain on daily life. Final scores range from 0–100, with 
higher scores indicating less pain. For the purpose of the analyses, the SF-36 
bodily pain scoring was inverted so that higher scores indicate more pain, where-
as higher CIS scores indicated more fatigue. The SF-36 was adapted to cover a 
retrospective timeframe of 2 weeks, in order to make the interval similar to the 
interval of the CIS fatigue. At baseline and 12 months, pain was also assessed 
using a numerical rating scale. 
During 2 weeks in the first month, the patients completed daily self-assess-
ments of pain and fatigue using a self-observation list, with Likert scales asking 
about today (27). The Beck Depression Inventory for primary care (BDIPC) was 
used to classify patients for depression. The BDI-PC is a 7-item self-report instru-
ment (range 0–21); a total score of ≥ 4 is suggestive of depression (28).
Statistical analyses
To assess whether fatigue changed over time on the group level, the course of 
fatigue over 1 year was analyzed graphically and using a longitudinal regression 
model (mixed model) correcting for repeated measures within patients, with CIS 
fatigue as the dependent variable and time as the independent variable. Next, 
1-month changes in individual fatigue and individual pain scores were calculat-
ed over consecutive months. A scatter plot was made showing the individual 
monthly changes in pain and fatigue. Next, Pearson’s correlations were used to 
analyze the correlations between monthly changes in pain and monthly changes 
in fatigue, at the same month and with a 1-month time lag. Finally, 3 longitudi-
nal regression models (mixed models) were used to analyze the relationships 
between change in pain level and change in fatigue level over time, corrected 
for repeated measurements within the same patient. It was analyzed whether 
a change in pain was associated with a change in fatigue over the same month 
(Figure 1, model 1), or with a change in fatigue 1 month later (Figure 1, model 2), 
or with a change in fatigue 1 month earlier (Figure 1, model 3). 
Age, sex, disease duration, rheumatoid factor positivity, HAQ score, and BDI-
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PC score were considered as possible confounders. The monthly pain and fatigue 
absolute scores at the beginning of the monthly differences in fatigue were en-
tered into the mixed model as covariates. 
We also tested whether the associations differed by sex and age (effect modi-
fication). The assumptions of the linear mixed-model analysis were checked by 
testing the linear relationship between the difference in CIS fatigue and the pre-
dicted values and graphically using a scatter plot of the predicted values versus 
the residuals. Fatigue was the dependent variable in all 3 models to facilitate 
comparison of regression coefficients between the 3 models (Figure 1). 
These analyses were repeated using the 2-week data set with daily changes 
in pain and fatigue. Data analysis was performed using the SAS system, version 
9.20.
Figure 1. Schematic representation of the models used to analyze the longitudinal association between 
fatigue and pain.
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Results
Patient characteristics
Two patients were excluded after the first measurement because of newly ac-
quired sleep apnea and a malignant lung tumor. A total of 228 patients were 
included and 198 patients who filled in at least 10 monthly CIS fatigue and pain 
questionnaires were included in the analyses. The 30 patients who were not 
included in the analysis were not different in baseline characteristics from the 
198 patients included in the analysis (data not shown). The included patients 
were mostly middle aged and the majority were women and rheumatoid factor 
positive (Table 1). Most patients had established disease, low levels of disease 
activity (DAS28 < 3.2), and low levels of disability (HAQ score). Clinical depres-
sion (BDI-PC score ≥ 4) seldom occurred. 
At baseline, the mean pain score or pain severity was moderate and the me-
an level of fatigue was higher than normal (CIS fatigue score < 27), but lower 
than severe (CIS fatigue score ≥ 35) (24). Severe fatigue at baseline (CIS fatigue 
score ≥ 35) was experienced in 40% of the patients. There were no large differ-
ences between baseline and follow up in any of the variables.
Medication
At baseline, 82 (41.4%) of 198 patients received disease-modifying antirheumat-
ic drug (DMARD) monotherapy, most often with methotrexate (n=50), sulfasala-
zine (n=17), and azathioprine (n=5). Twenty-three (12%) of 198 patients received 
DMARD combination therapy, usually with methotrexate. 
At baseline, 70 patients (35.4%) received a biologic agent and all were receiv-
ing tumor necrosis factor inhibiting agents, either as monotherapy or in combi-
nation with a DMARD. Eight patients (4%) stopped a biologic agent during the 
study and 12 (6%) started a biologic agent during the study. Thereby, 25 (13%) 
of 198 patients received oral prednisone. Medication use was missing in 23 pa-
tients.
Fatigue and pain over time
The monthly CIS fatigue scores are shown for those patients who were severely 
fatigued at baseline, and for those with heightened and normal fatigue levels 
(24) (Figure 2A). The mean CIS fatigue score for the total group dropped a little 
within the 1-year period (Table 1); in the 3 subgroups, the mean fatigue scores 
remained stable over time. According to the linear mixed-model analyses, on 
average there was no change in the level of fatigue over time (P = 0.80) or in the 
level of pain over time (P = 0.10) (Figures 2A and B). Figure 2B shows the course 
of both the monthly CIS fatigue and pain scores of the total sample over 1 year.
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Table 1. Patient characteristics at baseline and 12 months (n=198) *
baseline 12 months
Age, mean ± SD, years 56.7 ± 10.6
Sex, no. ( % ) women 126 (64)
Disease duration, years 10 (6, 17)
Rheumatoid factor positivity, no. (%) 153 (77)
DAS 28, mean ± SD 3.16 ± 1.24 3.09 ± 1.21
VAS general health 30 (15, 46) 25 (15,50)
SJC28 3 (1, 6) 4 (1, 6)
TJC28 2 (0, 4) 1 (0, 4)
ESR, mm/hour 8 (4-18) 10 (4-18)
CRP level, mg/liter† 0 (0, 8) 0 (0, 8)
Pain: NRS pain severity (range 0-10), 
mean ± SD
4.29 ± 2.46 3.86 ± 2.55
Pain: SF-36 bodily pain (range 
0-100),mean ± SD‡
35.23 ± 19.82 34.52 ± 21.34
CIS fatigue (range 8-56), mean ± SD 31.0 ± 12.4 30.0 ± 12.5
CIS fatigue, no. (%)
   Normal fatigue (<27) 78 (39.4) 87 (43.9)
   Heightened fatigue (27-34) 41 (20.7) 35 (17.7)
   Severe fatigue (≥ 35) 79 (39.9) 71 (35.9)
HAQ DI score 0.63 (0.13, 1.13) 0.63 (0.20, 1.13)
Hemoglobin level, mean ± SD mmoles/
liter
8.21 ± 0.72 8.15 ± 0.78
BDI-PC score ≥ 4, no. (%) 10 (5) 13 (6.6)
 * Values are the median (25th, 75th percentiles) unless otherwise indicated. DAS28 = Disease Activity 
Score in 28 joints; VAS = visual analog scale; SJC28 = 28 swollen joint count; TJC28 = 28 tender joint 
count; ESR = erythrocyte sedimentation rate; CRP = C-reactive protein; NRS = numerical rating scale; 
SF-36 = 36-item Short Form health survey; CIS = Checklist Individual Strength; HAQ = Health Assess-
ment Questionnaire; DI = disability index; BDI-PC = Beck Depression Inventory for primary care.† CRP 
levels <5 mg/liter are scored as 0. ‡ Scored on an inverted scale (where a higher score indicates less 
pain).
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Figure 2. A Course of fatigue in patients with no, mild, and severe fatigue. Mean Checklist Individual 
Strength (CIS) fatigue scores over 12 months of the total group (n = 198; —), patients who were severely 
fatigued at baseline (n = 96; – – ), and patients who were not severely fatigued at baseline (n = 102; -  -) 
are shown. B. The course of fatigue and pain over 1 year.
Monthly changes in pain and fatigue: simple correlations
The “naive” association between all individual changes in pain and changes in fa-
tigue, without correction for repeated measurements, is shown as a scatter plot 
in Figure 3. Each dot indicates a single time point with a monthly change in pain 
and a monthly change in fatigue, and each patient contributes up to 12 dots. 
From the graph it appears that there are fluctuations in pain and fatigue and that 
a change in fatigue is positively associated with a change in pain. On average, 
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there was no change in pain or fatigue; the mean ± SD monthly difference in pain 
was -0.02 ± 16.81 (P = 0.95) and the mean ± SD monthly difference in fatigue was 
-0.14 ± 8.12 (P = 0.41). 
Figure 3. Scatterplot indicating the individual monthly changes in pain and changes in fatigue.
It can be seen in Table 2 that changes in pain and changes in fatigue in the same 
month have a positive correlation (r = 0.42), i.e., an increase or decrease in fa-
tigue goes along with a change (increase or decrease) in pain in the same direc-
tion. It can also be seen that a change in pain in 1 month is negatively associated 
with a change in pain the next month (r = -0.41), i.e., an increase in pain is asso-
ciated with a decrease in pain the next month. The same is found for fatigue (r = 
-0.39). The same kind of correlations are found for changes in fatigue preceding 
changes in pain (r = -0.21) and changes in pain preceding changes in fatigue (r = 
-0.15).
Table 2. Association between fatigue and pain with Pearson’s correlation coefficients*
Δ pain,
same month
Δ fatigue,
1 month earlier
Δ pain,
1 month earlier
r 95% CI r 95% CI r 95% CI
Δ fatigue, 
same month
0.42   0.38, 0.45 -0.39 -0.43, -0.35 -0.15 -0.19, -0.11
Δ pain, 
same month
--- --- -0.21 -0.25, -0.17 -0.41 -0.44, -0.37
*Naïve correlations between monthly changes in fatigue and pain scores over 12 months. P<0.0001 
for all. 95% CI= 95% confidence interval
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Monthly changes in pain and fatigue: longitudinal regression.
For all regression models, adjustments were made for age, sex, and HAQ score, 
while monthly pain and fatigue scores were added as covariates. There were no 
large differences between the crude and the adjusted models, and only the re-
sults of the adjusted models are shown (Table 3). 
The results of the first model, representing the association between change
in pain and change in fatigue during the same month, showed a significant rela-
tionship (P < 0.0001). The positive beta coefficient (β = 2.00) indicated that more 
pain was associated with more fatigue during the same month. 
The second model, analyzing the longitudinal association between change in
pain level in the preceding month and change in fatigue 1 month later, indicated 
that a change in fatigue level was not related (β = 0.12, P = 0.32) to a change in 
pain level 1 month earlier. This indicates that an increase in pain level was not 
associated with an increase in fatigue level 1 month later. 
Model 3, analyzing the longitudinal association between change in fatigue 
level in the preceding month and change in pain level 1 month later, also indicat-
ed that a change in fatigue level is not related (β = -0.02, P = 0.83) to a change 
in pain level 1 month later. This indicates that an increase in fatigue level is not 
associated with an increase in pain level 1 month later. When similarly analyzing 
the longitudinal association between change in daily pain and fatigue scores, the 
same results were found (data not shown). The associations between change in 
pain score and change in fatigue score were not significantly different for men 
and women, nor did they vary with age.
Table 3. Association between fatigue and pain over time with linear mixed-models analysis*
β (95%CI) P-value
Model 1: Δ fatigue = Δ pain in same month 2.00 (1.77, 2.21) <0.0001
Model 2: Δ fatigue = Δ pain 1 month earlier 0.12 (-0.12, 0.36) 0.32
Model 3: Δ fatigue = Δ pain 1 month later -0.02 (-0.25, 0.20) 0.83
*A linear mixed-model analysis was performed, adjusted for age and sex, Health Assessment Ques-
tionnaire score, and the monthly pain and fatigue absolute scores at the beginning of the monthly 
differences in fatigue. 95% CI = 95% confidence interval.
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Discussion
This longitudinal study is the first study to examine the course of fatigue and pain 
in patients with RA in a period of 1 year with monthly measurements of fatigue 
and pain. The aim was to investigate whether changes in pain precede changes 
in fatigue, or vice versa, or whether pain and fatigue fluctuate together in time.
According to the results of this study, pain and fatigue showed monthly fluctu-
ations that were synchronous rather than showing a temporal relationship with 
a time lag. Within the timeframe of 1 year and monthly assessments, as well as 
daily assessments in 2 weeks, the results do not indicate that one precedes the 
other. There also was no indication that the results would differ for age and sex. 
The results showed that pain and fatigue scores were quite stable over 1 year. 
However, within the patients there was considerable monthly fluctuation in pain 
scores and in fatigue scores that was synchronous rather than showing a tem-
poral relationship with a time lag of 1 month. This was shown by the naive cor-
relations of change that, however, were not controlled for confounders and the 
absolute scores at the baseline of each change. One of the consequences of this 
correction using the linear mixed models is that the time-lagged effects of the 
naive correlations “disappeared.” Using the linear mixed-model analysis adjusted 
for age and sex, HAQ score, and monthly pain and fatigue scores at the begin-
ning of the monthly differences in fatigue, the strongest association was found 
in the correlations and the regression model, reflecting synchronous changes 
in pain and fatigue. According to the regression coefficient, a 1-point increase 
in pain score (range 0–100) was associated with a 2-point increase in fatigue 
score (range 8–56). Until now, the minimally important difference for the CIS 
fatigue score is not formally known, but a comparison with the health transition 
question of the SF-36 using our own data suggested that a minimally important 
difference may be -5 for improvement and +3 for worsening (data not shown). In 
a trial of cognitive–behavioral therapy for RA, the mean decrease in CIS fatigue 
score was 5 in the intervention group and 2 in the control group (29). Therefore, 
the size of the relationship between pain and fatigue appears to be relevant. 
The models using a time lag showed no significant association between chan-
es in pain and changes in fatigue. With this timeframe of 1 month, it cannot be 
said that one precedes or “causes” the other. To inform about probable cau-
sality, it would be informative if a change in pain precedes a change in fatigue 
(cause precedes effect) or vice versa. The time scale of such a temporal relation-
ship between pain and fatigue is unclear and might be day to day or month to 
month (17–19). Since we were primarily interested in the course of fatigue over 
1 year, we chose to assess fatigue and pain every month. The question, however, 
is whether monthly changes probably are too long. In a period of 2 weeks shortly 
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after baseline, patients filled in a diary with daily pain and fatigue scores. There-
fore, we were also able to analyze a temporal relationship between pain and 
fatigue on a day-to-day basis. In the end, the results of the monthly analyses and 
the daily analyses were the same, i.e., a strong association of pain and fatigue at 
the same time point, with no recognizable time lag. We identified several studies 
that looked into the relationship between pain and fatigue using daily measure-
ments in RA and in fibromyalgia (FM) (17,30 –32). It was found that patients with 
RA showed much variability in pain and fatigue levels within days, whereas there 
were no differences in pain and fatigue levels between days (17). It was suggest-
ed that the pattern of pain and fatigue was not explained by mood cycles (17). 
However, in another study of RA patients and consecutive daily fatigue assess-
ments, it was found that days with more frequent positive events were related to 
lower levels of same-day fatigue and higher levels of next-day fatigue in women, 
but not for men (18). In a study of patients with RA, it appeared that diurnal 
fluctuations in fatigue were independent of the circadian rhythm of cortisol or 
inflammatory activity, but rather reflect temporal changes as a consequence of 
sleep, rest, and physical activity throughout the day (17,30). In FM, it appeared 
that there was a diurnal relationship between pain and fatigue that probably was 
mediated by stress or sleep quality (31,32). It may be worthwhile to evaluate sex 
differences; for example, it has been found that especially younger women with 
multiple daily roles seemed to be vulnerable to the negative impact of RA fatigue 
(33). However, in our study, no difference between men and women was found. 
To our knowledge, no previous studies have analyzed the longitudinal relation-
ship between fatigue and pain in RA patients. The advantage of longitudinal anal-
ysis is that the individual development of both fatigue and pain in time can be 
investigated. There is one previous study, not in RA, in which the temporal rela-
tionship between pain and fatigue among primary care patients presenting with 
main symptoms of fatigue was analyzed (34). In this observational cohort study, 
pain and fatigue were measured at 1, 4, 8, and 12 months after baseline. The 
longitudinal associations were analyzed with 3 different models that were similar 
to those models used in the current study. The results indicated that changes in 
pain and fatigue are directly related in time, rather than showing a time lag in 
their relationship. This means that the findings of Nijrolder et al in the general 
care population are similar to the results of the current study (34).
A strength of our study is the monthly measurement of pain and fatigue dur-
ing 1 year. By measuring pain and fatigue with relatively short time intervals, we 
consider that we had a reasonable precise measurement of the courses of pain 
and fatigue to analyze their longitudinal association. The recall period of fatigue 
and pain was 2 weeks because a recall period of 4 weeks is considered relatively 
long for patients to remember their fatigue and pain levels. The bodily pain sub-
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scale of the SF-36 was modified to assess pain experienced in the last 2 weeks 
instead of the last 4 weeks to compare it with the CIS20, in which fatigue severity 
was assessed for the last 2 weeks. Another strength is few loss of data; 198 of the 
228 patients filled in at least 10 monthly CIS fatigue and pain questionnaires. It 
was hypothesized that patients with a well-controlled comorbidity, such as regu-
lated diabetes mellitus or regulated thyroid disease, would not experience extra 
fatigue from this underlying condition. Patients with multiple rheumatic diseases 
were not included; secondary Sjögren’s syndrome was allowed and regarded as 
an extra-articular manifestation of RA. 
A limitation of this study concerns the observational nature leading to a risk
of confounding. However, in the adjusted model, we corrected for the most im-
portant confounders. No other confounders were identified. The patients were 
consecutively included at regular visits, not at indication of having high pain lev-
els or high fatigue severity. Therefore, large changes in fatigue and pain after 
baseline were not found; on the other hand, the sample is representative for the 
RA population regarding levels of pain and fatigue. Another important consid-
eration is the different scaling for measuring pain and fatigue. The SF-36 bodily 
pain subscale was used to assess pain instead of a single pain visual analog scale 
because the subscale is composed of 2 items, which may be more valid than 1 
item. However, these 2 items have a limited number of response options, which 
may make it difficult to detect smaller changes in pain. One of the pain items 
considers the impact of pain on daily life, but it may not confound a relationship 
of pain with fatigue because the CIS fatigue subscale is about symptom severity, 
and impact on daily life is assessed using other CIS subscales. 
Seeing the important meaning of pain and fatigue for patients with RA, red-
uctions of pain and fatigue are recommendable goals for RA management (10). 
Further research is recommended in factors that can cause or perpetuate fa-
tigue in RA. Although pain could probably “cause” fatigue or fatigue could prob-
ably “cause” pain, probably both pain and fatigue are driven by common factors. 
Common factors maybe psychological factors, which could be investigated by a 
multidimensional model of fatigue using structural equation modeling.
In summary, the results of this 12-month longitudinal study of the monthly
temporal relationship between pain and fatigue show that in established RA, pain 
and fatigue have a synchronous association with a fluctuating pattern around an 
individual mean, rather than showing temporal associations. There is no indica-
tion that one precedes or causes the other, regardless of the time scale being 
days or months. The clinical implication is that both manifestations should be 
treated because it cannot be expected that an improvement in one is followed 
by an improvement in the other.
The association between fatigue and pain in rheumatoid arthritis 33
1
2
References
1. Conaghan PG, Green MJ, Emery P. Established rheumatoid arthritis. Baillieres 
Best Pract Res Clin Rheumatol 1999;13:561–75.
2. Hewlett S, Cockshott Z, Byron M, Kitchen K, Tipler S, Pope D, et al. Patients’ 
perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. 
Arthritis Rheum 2005; 53:697–702.
3. Repping-Wuts H, Fransen J, van Achterberg T, Bleijenberg G, van Riel P. Persistent 
severe fatigue in patients with rheumatoid arthritis. J Clin Nurs 2007;16:377–83.
4. Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid 
arthritis reflects pain, not disease activity.Rheumatology (Oxford) 2006;45:885–9.
5. Tack BB. Fatigue in rheumatoid arthritis: conditions, strategies, and consequenc-
es. Arthritis Care Res 1990;3:65–70.
6. Belza BL. Comparison of self-reported fatigue in rheumatoid arthritis and con-
trols. J Rheumatol 1995;22:639–43.
7. Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheu-
matic disease. J Rheumatol 1996;23:1407–17.
8. Crosby LJ. Factors which contribute to fatigue associated with rheumatoid ar-
thritis. J Adv Nurs 1991;16:974–81.
9. Huyser BA, Parker JC, Thoreson R, Smarr KL, Johnson JC, Hoffman R. Predic-
tors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum 
1998;41:2230–7.
10. Hewlett S, Chalder T, Choy E, Cramp F, Davis B, Dures E, et al. Fatigue in rheuma-
toid arthritis: time for a conceptual model. Rheumatology (Oxford) 2011;50:1004–6.
11. Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ,van den Bos GA.Impact of fatigue on 
health-related quality of life in rheumatoid arthritis. Arthritis Rheum 2004;51:578–85.
12. Wirnsberger RM, De Vries J, Jansen TL, Van Heck GL, Woutersn EF, Drent M. 
Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med 
1999;54:86–95.
13. Mengshoel AM, Forre O. Pain and fatigue in patients with rheumatic disorders. 
Clin Rheumatol 1993;12:515–21.
14. Tack BB. Self-reported fatigue in rheumatoid arthritis: a pilot study. Arthritis 
Care Res 1990;3:154–7.
15. Treharne GJ, Lyons AC, Hale ED, Goodchild CE, Booth DA, Kitas GD. Predictors 
of fatigue over 1 year among people with rheumatoid arthritis. Psychol Health Med 
2008;13:494–504.
16. Wolfe F, Michaud K. Fatigue, rheumatoid arthritis, and antitumor necrosis factor 
therapy: an investigation in 24,831 patients. J Rheumatol 2004;31:2115–20.
17. Stone AA, Broderick JE, Porter LS, Kaell AT. The experience of rheumatoid ar-
thritis pain and fatigue: examining momentary reports and correlates over one week. 
Arthritis Care Res 1997;10:185–93.
18. Davis MC, Okun MA, Kruszewski D, Zautra AJ, Tennen H. Sex differences in the 
relations of positive and negative daily events and fatigue in adults with rheumatoid ar-
34 Chapter 2
thritis. J Pain 2010;11:1338–47.
19. Nijrolder I, van der Windt DA, Twisk JW, van der Horst HE.Fatigue in primary 
care: longitudinal associations with pain. Pain 2010;150:351–7.
20. Meeus M, Nijs J, Meirleir KD. Chronic musculoskeletal pain in patients with the 
chronic fatigue syndrome: a systematic review. Eur J Pain 2007;11:377–86.
21. Meeus M, Nijs J. Central sensitization: a biopsychosocial ex- planation for chron-
ic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin 
Rheumatol 2007; 26:465–73.
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The 
American Rheumatism Association 1987 revised criteria for the classification of rheuma-
toid arthritis. Arthritis Rheum 1988;31:315–24.
23. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in 
arthritis. Arthritis Rheum 1980;23: 137–45.
24. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg 
G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994;38:383–
92.
25. Van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P. Physical and psycho-
social correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 
2010;49:1294–302.
26. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36). 
I. Conceptual framework and item selection. Med Care 1992;30:473–83.
27. Goedendorp MM, Peters ME, Gielissen MF, Witjes JA, Leer JW, Verhagen CA, et 
al. Is increasing physical activity necessary to diminish fatigue during cancer treatment? 
Comparing cognitive behavior therapy and a brief nursing intervention with usual care in 
a multicenter randomized controlled trial. Oncologist 2010;15:1122–32.
28. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in 
medical inpatients with the Beck Depression Inventory for primary care. Behav Res Ther 
1997;35:785–91.
29. Evers AW, Kraaimaat FW, van Riel PL, de Jong AJ. Tailored cognitive-behavioral 
therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. 
Pain 2002;100:141–53.
30. Dekkers JC, Geenen R, Godaert GL, van Doornen LJ, Bijlsma JW. Diurnal courses 
of cortisol, pain, fatigue, negative mood, and stiffness in patients with recently diag-
nosed rheumatoid arthritis. Int J Behav Med 2000;7:353–71.
31. Nicassio PM, Moxham EG, Schuman CE, Gevirtz RN. The contribution of pain, 
reported sleep quality, and depressive symptoms to fatigue in fibromyalgia. Pain 
2002;100:271–9.
32. Okifuji A, Bradshaw DH, Donaldson GW, Turk DC. Sequential analyses of daily 
symptoms in women with fibromyalgia syndrome. J Pain 2011;12:84–93.
33. Nikolaus S, Bode C, Taal E, van de Laar MA. New insights into the experience of 
fatigue among patients with rheumatoid arthritis: a qualitative study. Ann Rheum Dis 
2010;69:895–7.
34. Nijrolder I, van der Windt DA, Twisk JW, van der Horst HE. Fatigue in primary 
care: longitudinal associations with pain. Pain 2010;150:351–7. 
The association between fatigue and pain in rheumatoid arthritis 35
1
2

Chapter 3
Relationship between objectively assessed physi-
cal activity and fatigue in patients with rheuma-
toid arthritis:  inverse correlation of activity and 
fatigue
S.A.A. Rongen-van Dartel
J.W.J. Repping-Wuts
D. van Hoogmoed
H. Knoop
G. Bleijenberg
P.L.C.M. van Riel
J. Fransen
Arthritis Care & Research
 2014;66(6):852-60
38 Chapter 3
Abstract
Objective 
Fatigue is generally associated with low physical activity in patients with various 
chronic medical conditions. However, such an association has not been reported 
among patients with rheumatoid arthritis (RA). The objectives of this study were 
to investigate whether daily activity level is associated with fatigue in patients 
with RA, and whether pain, disability, coping, and/or cognition are associated 
with the level of daily activity.
Methods 
Patients with RA who visited our outpatient clinic were recruited consecutively. 
Fatigue severity was measured using the Checklist Individual Strength (CIS20). 
Physical activity was measured for 14 consecutive days using an ankle-worn ac-
tometer. The daily activity level of each patient was calculated, and each patient 
was classified as having a low or high activity level with respect to the group 
average. Data were analyzed by linear regression.
Results 
A total of 167 patients were included in the analysis; 25% had a low activity level 
and 75% had a high activity level. A regression analysis revealed that higher ac-
tivity levels were associated with reduced fatigue (P = 0.008). The mean ± SD CIS 
fatigue score was 30.9 ± 12.3 among the patients with a high activity level and 
35.7 ± 12.8 among the patients with a low activity level (P = 0.03). Pain, disability, 
coping, and cognition were not associated significantly with daily activity level.
Conclusion 
Among patients with RA, a higher level of daily physical activity was associated 
with reduced levels of fatigue. This relationship was not explained by differences 
in sex, age, disease duration, pain, disability, or other fatigue-related factors.
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Introduction
Fatigue is a common symptom among patients with rheumatic diseases, includ-
ing rheumatoid arthritis (RA) (1). As many as 40% of patients with RA experience 
severe fatigue (defined as a Checklist Individual Strength (CIS) fatigue score ≥35), 
and fatigue often causes debilitating and restricted daily functioning (2–6). 
In patients with RA, fatigue can be associated with pain, disability, depressive
thoughts, anxiety, worrying, feelings of helplessness, reduced self-efficacy, sleep 
disturbances, and limitations in social functioning (7–9). Based on these findings, 
pain and disability, and not inflammation per se, and psychosocial factors may be 
important contributors to the presence and persistence of fatigue. In addition, 
it remains unclear which treatments are effective for treating fatigue in RA pa-
tients. This uncertainty can contribute to fatigue being neglected during health 
care visits. However, some randomized controlled trials (RCTs) suggest that both 
cognitive–behavioral therapy and physical exercise can be effective for treating 
fatigue in patients with RA (10,11). 
With respect to chronic fatigue syndrome (CFS), graded exercise training and 
cognitive–behavioral therapy are the only 2 interventions that are considered 
to be effective (12–15). Patients with CFS are significantly less physically active 
compared to age-matched healthy controls (16–18), and CFS patients with “per-
sistently passive” daily activity patterns are more inclined to avoid physical exer-
tion and experience more physical dysfunction (18). In this respect, “persistently 
passive” patients were defined as patients with an activity level that was lower 
than the group average for at least 90% of the total observation period; the re-
maining patients were defined as “active” (18). 
Decreased levels of physical activity have been reported among patients with
RA (19–26). For example, an international study reported that the majority of pa-
tients with RA did not engage in regular physical exercise (with physical exercise 
defined as ≥30 minutes of exercise with some shortness of breath and/or per-
spiration) (23). The percentage of Dutch patients with RA who met the recom-
mendation for physical activity was similar to the general population; however, 
among participants ages 45–64 years, the average number of minutes per week 
performing physical activity was significantly lower in the RA patient population 
than in the general population (19). Both the belief that physical activity can help 
manage the disease and increased motivation to engage in physical activity can 
drive higher levels of physical activity among the RA population (27). Among oth-
er patient groups, including patients with multiple sclerosis, increased physical 
activity (measured objectively) has been associated with decreased fatigue (28). 
With respect to RA, daily physical activity has not been measured objectively, 
and it is unclear whether fatigue and physical activity are correlated. Daily phys-
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ical activity can also be influenced by pain, disability, coping, and/or cognition. 
Clarifying how these factors can influence activity levels may provide important 
clues for developing an effective treatment for fatigue in patients with RA. Daily 
physical activity can be measured objectively using actigraphy, providing a reli-
able, valid measure of human physical activity (17,29). 
The objectives of this study were to investigate whether objectively measur-
ed activity levels and activity patterns are associated with fatigue levels in pa-
tients with RA, and whether pain, disability, coping, and/or cognition are associ-
ated with, or influence, the level of activity among patients with RA.
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Materials and methods
Design
This cross-sectional study was part of a cohort study that was designed to de-
termine which factors are associated with fatigue in RA. The study was approved 
by the Medical Ethics Committee Arnhem-Nijmegen in The Netherlands, and all 
participants provided written informed consent.
Included patients
From June 2006 through October 2007, consecutive patients ages 18–75 years 
who visited their rheumatologist at the outpatient clinic of the Radboud Uni-
versity Medical Center at Nijmegen were invited to participate. Patients were 
informed by either their rheumatologist or nurse specialist, and the information 
was provided both verbally and in writing. 
Inclusion criteria included a diagnosis of RA in accordance with the 1987 ACR
classification criteria (30), age 18–75 years, and the ability to read and write 
Dutch. Patients were excluded from the study if they had a second rheumatic dis-
ease, a history of malignancies and/or other chronic fatigue–related comorbidi-
ty, or a current diagnosis of depression, or were currently receiving psychological 
or psychiatric treatment. Patients with a comorbidity that was well controlled 
were eligible to participate; such comorbidities included regulated thyroid dis-
ease (free T4 ≥ 8 pmoles/liter and thyroidstimulating hormone ≤ 1.0 unit/liter), 
controlled diabetes mellitus (with normalized urine and blood glucose values of 
45–66.6 mg/dl and 72–100.8 mg/dl, respectively, and glycosylated hemoglobin 
values < 8.0%), mild nonrestrictive chronic obstructive pulmonary disease, and 
successfully treated nonmetastasized basal cell carcinoma or squamous cell car-
cinoma in the skin.
Data collection
Patient characteristics (sex, age, and body mass index (BMI)), disease character-
istics (disease duration and rheumatoid factor), comorbidity, and medication use 
were recorded by research nurses at the time of inclusion in the study. Blood 
samples were obtained and used to determine erythrocyte sedimentation rate, 
C-reactive protein level, and hemoglobin level. Upon inclusion, disease activity 
was assessed by the rheumatologist or by a specialized rheumatology nurse us-
ing the Disease Activity Score in 28 joints. At inclusion, psychosocial variables, 
including beliefs regarding the somatic and nonsomatic causes of fatigue, coping 
strategies, and catastrophizing, were recorded using patient questionnaires that 
were answered using a computer. Daily activity was recorded objectively using 
an actometer for 14 consecutive days immediately following inclusion.
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Fatigue among patients with RA could have multiple determinants, and previ-
ous studies using multidimensional models have documented the importance of 
variables such as mood, coping processes, and self-efficacy (4,31). Therefore, we 
collected a set of psychosocial variables that could potentially influence fatigue. 
Fatigue severity was assessed using the fatigue severity subscale of the CIS20 
(31). The CIS fatigue subscale consists of 8 items, each of which is scored using 
a 7-point Likert scale (yielding a total score of 8–56). The 8 items are designed 
to measure the patient’s fatigue level during the previous 2 weeks, with a higher 
score on the CIS fatigue indicating a higher level of fatigue. A total score of ≥ 35 
(which is 2 SDs above the mean score for a healthy control group) indicates se-
vere fatigue (31). The CIS20 has been validated and is considered reliable under 
many conditions; this checklist also has been used previously to assess patients 
with RA (8,31). 
Pain was assessed using the bodily pain subscale of the Short Form 36 (SF-36) 
health survey, which determines the patient’s pain severity and pain-related lim-
itations experienced during the previous 4 weeks (32). The SF-36 bodily pain 
subscale score ranges from 0–100, with a higher score indicating less severe pain 
and fewer pain related limitations. Pain severity was also assessed using a nu-
merical rating scale regarding pain in the current situation (range 0–10, where 0 
= no pain and 10 = extreme pain). 
Daily functioning was assessed using the Health Assessment Questionnaire
(HAQ) disability index and the physical functioning subscale of the SF-36 (33). 
The Beck Depression Inventory for primary care (BDIPC) was used to classify
patients for clinical depression(34). The BDI-PC is a 7-item self-reporting instru-
ment that is scored by totaling the highest scores from each of the 7 individual 
items. Each item is rated on a 4-point scale (ranging from 0–3); therefore, the 
maximum total score for the BDI-PC is 21. A total score of ≥ 4 on the BDI-PC indi-
cates clinical depression (34). 
Beliefs regarding the somatic and nonsomatic causes of fatigue were measur-
ed using a modified version of the Causal Attribution List. Self-efficacy with re-
spect to fatigue was measured using the Self-Efficacy Scale 28, a questionnaire 
containing 7 items that are scored on a 4-point Likert scale. 
Coping strategies were measured using the Modified Pain Coping Inventory
for Fatigue (MPCI-F), which is scored on a 4-point Likert scale and is based on the 
Pain Coping Inventory. In the MPCI-F, “pain” is replaced with “fatigue”. 
To assess catastrophizing, the Fatigue Catastrophizing Scale (FCS) was used.
The FCS was derived from the Pain Catastrophizing Scale, with the word “pain” 
replaced with “fatigue” (35). 
Daily physical activity, including general daily activities at home, at work, du-
ring rest, and during leisure time, was measured using an actometer (Actilog 
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version 4.1), an ankle-worn motion-sensing device that registers and quantifies 
daily physical activity (17,18). The actometer contains a piezoelectric sensor that 
is sensitive in 3 directions. Acceleration of the sensor above a predefined thresh-
old (the actometers were all calibrated to have the same threshold) is considered 
to be activity and is stored in the device’s internal memory. The actometer’s 
counter was read and reset each second by the microcontroller, which added the 
value to an integration counter that was set to 5 minutes. Therefore, the activity 
score was measured every 5 minutes, with a maximum of 300 scores counted. 
Each actometer was calibrated before collecting data. The actometer’s out-
put was an activity count that was the weighted sum of the number of accelera-
tions measured during a 5-minute period. To obtain a valid measurement of the 
patient’s daily activity, the patient was instructed to wear the actometer for 14 
consecutive days and to remove it only during swimming and bathing; therefore, 
all activities throughout the day (except swimming and bathing) were recorded.
Actometer data
If a non–actometer-wearing period exceeded 3 hours, the day was recorded as 
“nonvalid.” Patients with >2 nonvalid registration days were excluded from the 
analysis; in case of 1 or 2 nonvalid days, data for these days were inserted using 
the mean values of the remaining 10 or 11 valid days. Individual physical activity 
was analyzed using the Actilog Analyzer software, version 4.10. The mean physi-
cal activity score of all included patients was calculated to determine the average 
daily physical activity over the entire 12-day period, and this was expressed as 
the average number of accelerations per 5-minute interval. To subtype activity 
levels among the patients with RA, we assigned each patient to 1 of 2 groups: 
patients with low daily physical activity and patients with high daily physical ac-
tivity. 
In accordance with van der Werf et al, the patients with a low activity level 
were defined objectively as those patients whose activity level was lower than 
the group average for at least 90% of the total observation period; the remaining 
patients were defined as having a high daily activity level (18). Figure 1 shows 
examples of the daily activity pattern of a patient with a high daily activity level 
(Fig.1A) and a patient with a low daily activity level (Fig.1B).
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Figure 1. A, A rheumatoid arthritis (RA) patient with a high activity level. B, A RA patient with a low 
activity level. The y-axis shows the activity count and the x-axis shows the day number and the mean 
physical activity during each day (M). The mean activity levels of all valid days and their SDs are shown 
in the top right-hand corner of each graph. The dark gray box is the first valid registration day (day 2).
Statistical analysis
Baseline differences between the high and low daily activity level groups were 
analyzed using Student’s t-test, the Mann-Whitney U test, or the chi-square test, 
where appropriate. To determine whether there was an association between fa-
tigue and daily physical activity, continuous and dichotomous (low and high ac-
tivity level) linear regression analyses were performed, with CIS fatigue score as 
the dependent variable and daily physical activity as the independent variable, 
with correction for potential confounders. Age and sex were predetermined for 
inclusion in the adjusted linear regression model, whereas all other variables 
were considered to be confounders if the regression coefficient of the main ef-
fect (daily physical activity) in the linear regression model changed by ≥ 10% after 
adding the variable (one of the baseline characteristics) (Table 1) to the model. 
To analyze the association between fatigue and activity score divided into 
equal group sizes, we performed a sensitivity analysis using a linear regression 
analysis with activity divided into quartiles. The association between activity lev-
el (low and high) and the occurrence of fatigue (severe and not severe) was also 
analyzed in a 2 x 2 table using the chi-square test; for this analysis, fatigue was 
classified as either severely fatigued (CIS fatigue score ≥ 35) or not severely fa-
tigued (CIS fatigue score < 35) (6). All analyses were performed using the PASW 
statistics package, version 18.0 (SPSS).
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Results
Patients
Of the 230 patients who were included in the study, 181 (78%) were willing to 
wear an actometer for 14 consecutive days. The first and last days of data col-
lection were excluded from the analysis, yielding 12 complete continuous days 
of data. One hundred sixty-seven (92%) of these 181 patients had at least 10 
daily measurements of activity and were included in the analysis (Table 1). We 
found no statistically significant difference in baseline characteristics between 
the 49 patients who were unwilling to wear an actometer and the 181 patients 
who agreed to wear an actometer, nor did we find a difference between the 14 
patients with an insufficient number of daily measurements and the 167 patients 
who were analyzed (data not shown). Based on our definition (see Methods), 
42 patients were classified as having a low activity level, and the remaining 125 
patients were classified as having a high activity level.
Table 1. Baseline characteristics of 167 patients with RA with a low or high daily activity level*
Low activity level 
(n=42)
High activity level 
(n=125)
P-value
Age, years 56.78 (11.03) 54.79 (10.59) 0.30
Female sex, no. (%) 33 (79)  67 (54) 0.004†
Body mass index, median (IQR) kg/m2 26.72 (24.34-
29.04)
24.51 (22.69-
26.68)
0.004†
Positive rheumatoid factor, no. (%) 31 (73.8) 92 (73.6) 0.99
Disease duration, median (IQR) years 9.5 (6-17.25) 10 (5.0-16) 0.43
Cardiovascular disease, no. (%) 6 (14) 18 (14) 0.99
COPD, no. (%) 0 (0) 5 (4) 0.19
Diabetes mellitus, no. (%) 1 (2.4) 8 (6.4) 0.32
DMARD use, no. (%) 33 (78.6) 110 (88) 0.13
Biologic agent use, no. (%) 18 (42.9) 43 (34.4) 0.33
Corticosteroids, no. (%) 11 (26.2) 31 (24.8) 0.86
Statin use, no. (%) 3 (7.1) 3 (2.4) 0.15
DAS28 (range 0–10) 3.28 (1.18) 3.07 (1.23) 0.32
Swollen joint count 28 (range 0–28), 
median (IQR) 
3 (2-6) 3 (2-6) 0.65
Tender joint count 28 (range 0–28), medi-
an (IQR) 
2 (1-4.25) 1 (0-4) 0.24
ESR, median (IQR) mm/hour 8 (4-16.5) 7 (4-13) 0.31
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Low activity level 
(n=42)
High activity level 
(n=125)
P-value
CRP, median (IQR) mg/liter‡ 0 (0-8.75) 0 (0-6) 0.26
Hemoglobin, mg/dl 147.6 (10.27) 149.37 (16.76) 0.89
NRS pain severity (range 0–10) 4.76 (2.69) 4.26 (2.36) 0.25
SF-36 bodily pain (range 0–100) 63.94 (18.62) 63.61 (19.07) 0.96
CIS fatigue (range 8–56) 35.74 (12.84) 30.88 (12.27) 0.03†
HAQ DI (range 0–3) 0.80 (0.56) 0.65 (0.60) 0.16
SF-36 physical functioning (range 0–100) 56.31 (23.56) 59.96 (24.20) 0.40
SF-36 social functioning (range 0–100) 73.51 (21.60) 75.60 (23.43) 0.66
SCL-90 sleep disturbances (range 3–15) 6.31 (2.98) 5.90 (2.92) 0.24
Depression, BDI-PC 4, no. (%) 0 (0%) 9 (7.2%) 0.56
CAL somatic (range 3–12), median (IQR) 6 (5-7) 6 (6-7.5) 0.24
CAL nonsomatic (range 3–12) 9.1 (1.82) 8.66 (1.95) 0.21
SES28 (range 7–28) 18.83 (3.75) 19.73 (3.55) 0.17
MPCI-F worrying (range 9–36), median 
(IQR) 
14 (11-17.3) 14 (11-17) 0.72
MPCI-F retreating (range 7–28) 12.62 (3.95) 11.84 (3.67) 0.24
MPCI-F resting (range 5–20) 12.24 (2.99) 11.41 (2.93) 0.12
MPCI-F fatigue transformation (range 
4–16) 
8.71 (2.45) 8.32 (2.53) 0.37
MPCI-F reducing demands (range 3–12) 6.14 (1.84) 6.67 (2.01) 0.13
MPCI-F distraction (range 5–20) 11.93 (2.40) 11.06 (3.22) 0.06
FCS rumination (range 0–16) 3.86 (3.75) 4.46 (3.77) 0.37
FCS helplessness (range 0–24) 3.60 (4.42) 4.07 (4.27) 0.35
FCS magnification (range 0–12) 0.88 (1.74) 1.17 (1.91) 0.28
*Values are the mean (SD) unless indicated otherwise. IQR = interquartile range; COPD = chronic 
obstructive pulmonary disease; DMARD = disease-modifying antirheumatic drug; DAS28 = Disease 
Activity Score in 28 joints; ESR = erythrocyte sedimentation rate; CRP = C-reactive protein; NRS = nu-
merical rating scale; SF-36 = Short Form 36 health survey; CIS = Checklist Individual Strength; HAQ  = 
Health Assessment Questionnaire; DI = disability index; SCL-90 = Symptom Checklist-90; BDI-PC = Beck 
Depression Inventory for primary care; CAL = Causal Attribution List; SES28 = Self-Efficacy Scale 28; 
MPCI-F = Modified Pain Coping Inventory for Fatigue; FCS = Fatigue Catastrophizingn Scale.† Statisti-
cally significant.‡ CRP levels 5 mg/liter were scored as 0.
High daily activity level versus low daily activity level
Univariate analyses
Of the 167 patients with RA who were included in the analysis, 44% were severe-
ly fatigued (CIS fatigue score ≥ 35), and the overall mean ± SD CIS fatigue score 
was 32.1 ± 12.6. The mean ± SD daily physical activity score of 167 patients was 
73 ± 27. Therefore, the average activity level of patients with RA lies between 
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healthy controls and patients with CFS, and is similar to other chronic conditions 
(Table 2). The RA patients with a high activity level had a mean ± SD daily activity 
score of 83 ± 23, and the patients with a low activity level had a mean ± SD daily 
activity score of 43 ± 9. Table 1 summarizes separately the clinical characteristics 
of the 42 low activity (25%) and the 125 high activity (75%) patients with RA. 
Our analysis revealed no significant difference between the high activity and low 
activity groups with respect to comorbidity or medication use. Conversely, the 
high activity patients had significantly lower CIS fatigue scores than the low ac-
tivity patients. Moreover, the low activity patient group had significantly higher 
BMI scores and a significantly higher percentage of women. No differences were 
detected between the 2 groups with respect to other characteristics, including 
pain, disability/function, and any of the variables that reflect coping and cogni-
tion.
Table 2. Overview of studies that measured daily physical activity using an ankle-worn accelerometer, 
with activity count as the outcome measure*
Study Participants (n) Total no. of 
registered days
Activity count, 
mean ± SD
current study RA patients (167) 12 73 ± 27
van der Werf et al, 2000 (18) Chronic fatigue syndrome 
(277)
12 66 ± 22
Healthy controls (47) 12 91 ± 25
Servaes et al, 2002 (42) Severely fatigued di-
sease-free patients with 
breast carcinoma (57)
12 76.1 ± 22.5
Non-severely fatigued 
disease-free patients with 
breast carcinoma (93) 
12 79.1 ± 20.8
Patients without a history of 
breast carcinoma (78)
12 76.9 ± 15.5
Steele et al, 2003 (41) COPD patients (41) 5 87.4 ± 38.8
* RA = rheumatoid arthritis; COPD = chronic obstructive pulmonary disease.
Relationship with fatigue
To analyze the relationship between activity level and fatigue, both age and sex 
were predetermined for inclusion in the adjusted linear regression model, in 
which BMI, pain severity, and the HAQ were included as confounders. The anal-
ysis revealed that the relationship between activity and fatigue was linear (Table 
3), with each unit increase in activity correlating with a 0.08 decrease in the 
fatigue score. To facilitate the interpretation of these results, Figure 2 shows box 
plots of the fatigue levels of the low and high daily activity level groups. The plot 
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shows that the median CIS fatigue score of the low activity patients was higher 
than the median CIS fatigue score of the high activity patients (36 versus 31; P 
= 0.03). 
Table 4 summarizes the results of the linear regression analysis between low
 and high activity, adjusted for age, sex, HAQ, BMI, and pain. The table shows 
that high activity patients with RA scored an average of 4 points lower for fatigue 
than low activity patients with RA. The CIS fatigue score is usually divided into 
severe fatigue (CIS ≥35) and elevated/normal fatigue (CIS <35). A chi-square test 
revealed a significantly higher percentage of severely fatigued (i.e., CIS ≥35) pa-
tients in the passive group than in the active group (60% versus 38%; P = 0.017).
Sensitivity analysis
Table 4 also shows the linear regression analysis of sensitivity with activity di-
vided into quartiles; this analysis was adjusted for age, sex, HAQ, BMI, and pain. 
Significantly higher fatigue scores (P < 0.001) were found between the low activ-
ity patients (i.e., the first quartile) and the high activity patients (i.e., the fourth 
quartile).
Table 3. Linear regression model of fatigue (continuous) versus daily activity (continuous)*
Β P-value 95% CI
Unadjusted model
  Constant 38.49 <0.001 32.94, 44.04
  Activity -0.087 0.017 -0.158, -0.016
Adjusted model†
  Constant 49.90 <0.001 34.62, 65.19
  Activity -0.082 0.008 -0.14, -0.021
* P values and 95% confidence intervals (95% CIs) are based on the regression coefficient. B = regres-
sion coefficient; constant = intercept. † The adjusted model was corrected for age, sex, the disability 
index of the Health Assessment Questionnaire, body mass index, and the numerical rating scale for 
pain. 
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Table 4. Results of the unadjusted and adjusted linear regression models of fatigue (continuous) for 
low versus high activity*
Β P-value 95% CI
Unadjusted model
  Constant 35.74 <0.001 31.96, 39.52
  High activity level -4.86 0.03 -9.23, -0.49
Adjusted model†
  Constant 46.20 <0.001 31.94, 60.47
  High activity level -4.42 0.018 -8.059, -0.78
Adjusted model (divided into 
quartiles)†
  Constant 41.331 <0.001 28.47, 54.19
  First quartile 5.698 0.014 1.16, 10.24
  Second quartile 3.467 0.126 -0.99, 7.92
  Third quartile 0.198 0.928 -4.10, 4.50
  Fourth quartile 0 NA NA
* P values and 95% confidence intervals (95% CIs) are based on the regression coefficient. B = re-
gression coefficient; constant = intercept; NA = not applicable. † The adjusted model was corrected 
for age, sex, the disability index of the Health Assessment Questionnaire, body mass index, and the 
numerical rating scale for pain.
Figure 2.  Box plots of the Checklist Individual Strength (CIS) fatigue scores are shown for the 2 activity 
groups. The bold horizontal bars indicate the median and the upper and lower boxes indicate the quar-
tiles. The whiskers indicate the minimum and maximum values
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Discussion
Based on the results obtained from this study, patients with RA who have a high 
level of daily physical activity have less fatigue than patients with low daily phys-
ical activity; moreover, the level of activity is not associated with pain, disability, 
coping, or cognition. 
Activity level was measured objectively, and patients who had an activity lev-
el that was lower than the group average for more than 90% of the observation 
time were defined as having a low activity level (see Methods). Therefore, the 
classification of each patient into either the low or high activity group was based 
on the activity of his/her fellow patients. The majority of patients (75%) were 
classified as having high activity and the remaining 25% were classified as having 
low activity. Overall, nearly half of all patients had severe fatigue, as determined 
using the CIS questionnaire. According to the CIS definition of severe fatigue, 
this means that many of the RA patients in this study had a fatigue level that was 
similar to the level in patients with CFS. Based on the regression analysis, higher 
activity scores were associated with lower fatigue scores, even after correcting 
for potential confounders.
Consistent with this analysis, the average fatigue score among patients with
high activity was 5 points lower than that for patients with low activity. This 
difference is likely relevant, as a trial that examined the effect of cognitive be-
havioral therapy in RA patients reported a 6-point difference in CIS fatigue score 
between the 2 groups (36). 
In addition to higher fatigue levels, RA patients who have more pain and dis-
ability would likely have lower average levels of activity. Moreover, activity lev-
el can also be associated with coping and cognition; patients with “passive” or 
“unproductive” coping styles can also have lower levels of activity. However, our 
results revealed no strong indication that either coping or cognition is correlated 
with activity level. Notably, coping, cognition, pain, and disability are all associat-
ed with fatigue in patients with RA (8). 
To the best of our knowledge, this is the first study to objectively measure
and relate the level of physical activity and fatigue in patients with RA. A few 
other studies have investigated the association between physical activity and 
fatigue, and none of these studies included patients with RA. It is important to 
note that decreased physical activity has been associated with increased fatigue 
in patients with CFS, Sjögren’s disease, and breast cancer (37,38). 
Nevertheless, one cannot necessarily conclude that “passiveness” causes fa-
tigue (or vice versa). Indeed, both scenarios are conceivable; fatigue may lead 
to decreased activity, and decreased activity may lead to fatigue. To address 
the possibility of a clinically relevant causal relationship, an RCT should be per-
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formed. For example, one can test whether increasing activity through exercise 
and/or training can reduce fatigue in severely fatigued RA patients with low daily 
activity (12). 
One question that remains is whether RA patients have low levels of fatigue 
relative to healthy subjects and/or the general population. Although several stud-
ies have investigated the activity levels of RA patients, comparing the findings 
across studies is problematic because of differences in the assessment methods 
(e.g., assessment by questionnaire versus objective measurements) (19–26,39). 
Based on the published literature, patients with RA appear to have a relatively 
low level of physical activity. In particular, a study comparing RA patients from 
various countries found that up to 80% of patients in some countries were “phys-
ically inactive” (23); the authors defined “physically active” as ≥ 30 minutes of 
exercise with at least some shortness of breath and/or perspiration (23). 
The type of accelerometer that we used in this study has been used in other
studies, including studies with healthy controls and other patient groups (Table 
2). Therefore, the group averages can be compared (albeit indirectly), although 
groups may not be fully comparable with respect to age or sex. Nevertheless, 
the activity level of patients with RA lies somewhere between the activity level 
of patients with CFS and healthy controls, but lower than the activity level of pa-
tients with breast cancer or Sjögren’s syndrome. Moreover, compared to healthy 
controls, patients with chronic diseases have decreased daily activity levels, in-
cluding patients with diabetes mellitus (40), Sjögren’s syndrome (37), chronic ob-
structive pulmonary disease (41), breast carcinoma (42), and hereditary motor 
and sensory neuropathy type 1 (43). 
The strength of our study is the large number of patients and the measurem-
ent of daily activity for 12 consecutive days. In addition, because nonrandomized 
studies always carry a risk of confounding, the analyses were adjusted for several 
confounding factors. Because the difference between the adjusted and unad-
justed models was negligible, it is unlikely that any residual confounding factors 
biased the association. Moreover, actigraphy (i.e., the use of a uniaxial actome-
ter) is a reliable and valid instrument for continuously and objectively measuring 
physical activity (18,29,44). However, a limitation is that the actometer results 
cannot be reliably correlated to energy expenditure (45). Therefore, patients 
with a low daily activity level should be advised to increase their physical activ-
ity, although we cannot precisely define or recommend how many minutes one 
should be physically active; thus, current recommendations advise patients to 
engage in physical activity for ≥ 30 minutes/day, ≥5 days/week. 
Another limitation of our study might be the substitution of missing actome-
ter values with the mean values of the remaining 10 or 11 days. However, be-
cause only 7 (4.2%) of the 167 patients had 1 or 2 missing values, the effect of 
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this approach was likely negligible. Another limitation could be the cross-section-
al design of this study. To determine whether the relationship between fatigue 
and daily activity level is causal, it would have been an advantage if longitudinal 
data could be used. If changes in daily activity level would precede changes in 
fatigue, this could be interpreted causally. A stronger design to determine causal 
relationships, however, is an RCT. 
In summary, we report that the level of activity and the level of fatigue are
associated in patients with RA; however, which factors influence the level of 
activity in RA patients remains unclear. With respect to fatigue in RA patients, 
which treatments are effective also remains unclear. Nevertheless, reducing pain 
and inflammation should have high priority in managing RA, and reducing pain 
may also reduce fatigue. However, RA patients whose disease is managed well 
can still develop severe fatigue (6). In addition to the association between fa-
tigue and decreased activity revealed here, fatigue can also be associated with 
pain, disability, coping, and cognition (7–9). RCTs have suggested that cognitive 
behavioral therapy and physical exercise can be beneficial in treating fatigue in 
RA patients (10,11). Although several RCTs found that exercise is beneficial for 
RA patients (46), only one relatively small trial found that exercise may be bene-
ficial specifically for fatigue in RA patients (10). Evidence from studies of CFS also 
suggests that exercise may be beneficial for RA patients (10,47). Exercise might 
be particularly relevant to patients with low daily activity levels. For relatively 
active patients, other factors, such as changing dysfunctional beliefs with respect 
to fatigue or reducing their “all-or-nothing” behavior, may be more important 
(48). Future studies should investigate whether fatigue in patients with RA can 
indeed be treated effectively with exercise or another form of graded activity, 
particularly among patients who have a low level of physical activity and chronic 
severe fatigue.
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Abstract
Objective 
Many rheumatoid arthritis (RA) patients experience severe fatigue and have low 
levels of physical activity. However, it is unclear how levels of fatigue and phys-
ical activity in RA compare to the general population. Objectives of this study: 
1) compare the level of physical activity and the level of fatigue between RA 
patients and the general Dutch population, 2) investigate factors associated with 
self-reported physical activity in RA and 3) describe sport activities of RA patients 
and their limitations to participate in sports. 
Methods 
A sample of the general Dutch population was obtained as part of the Nijme-
gen Biomedical Study (n=3764); fatigue and physical activity were self-assessed. 
Across the Netherlands, 740 RA patients filled out an online survey in 2013 and 
2014 on physical activity. Fatigue was assessed in 228 RA patients from the Ni-
jmegen RA cohort (2006-2007).
Results 
RA patients reported lower physical activity per week (median 24.6 hours) than 
the general population (median 33.0 hours) and RA patients had a significant 
higher fatigue level according to the Shortened Fatigue Questionnaire (16 versus 
9, range 4-28). In RA, lower level of physical activity was associated with older 
age and longer disease duration. Fitness, swimming, strength training and walk-
ing were the most popular sports among RA patients. Most frequently mentioned 
limitations were physical impairment, not aware of the options, fear of injuries.
Conclusion 
Compared to the general Dutch population, RA patients showed higher levels 
of fatigue and were less physically active. RA patients should be encouraged to 
increase physical activity with as consequence a possible reduction in fatigue. 
Comparison of physical activity and level of fatigue 61
1
2
3
4
Introduction
Fatigue is a frequent complaint in patients with Rheumatoid Arthritis (RA), even 
among patients with low and moderate levels of disease activity (2, 3). As much 
as 40% of the patients with RA may have severe fatigue (2). Moreover, fatigue in 
RA is a patient-relevant complaint: patients with RA express their fatigue as un-
predictable, overwhelming and different from normal tiredness (3) and it is often 
perceived as debilitating and restricting daily functioning (2, 4-6). Fatigue in RA 
potentially has a large impact on quality of life and patients give high priority to 
fatigue reduction (7). 
One of the factors associated with fatigue in RA may be physical activity: in
patients with RA but also in patients with other chronic conditions such as chron-
ic fatigue syndrome (CFS), Sjögren’s syndrome, cancer and Parkinson’s disease, a 
higher level of fatigue is associated with a lower level of physical activity (8-11). 
The role of fatigue and physical activity as ‘cause’ and ‘effect’ are unclear, how-
ever increasing the level of activity might reduce fatigue in RA (12, 13).
Although it appears that fatigue is severe and prevalent in RA, it may seem 
that in the general population fatigue is also quite prevalent. Whether in RA fa-
tigue indeed is more severe than in the general population is not clear, although 
two small studies show that this might be the case (5, 14). In other chronic dis-
eases, notably patients with multiple sclerosis (MS) and in cancer survivors, it 
has been shown that fatigue was more severe than in the general population 
(15, 16). Also, physical activity levels (subjectively or objectively measured), are 
significantly lower in patients with MS, CFS, Chronic Obstructive Pulmonary Dis-
ease (COPD) and type-2 diabetes mellitus compared to healthy subjects (8, 17). 
As fatigue and physical activity are related in several chronic diseases, the level 
of physical activity in RA patients might also be relevantly lower compared to the 
general population. 
In the past, several studies compared physical activity levels of RA patients 
and healthy controls, and demonstrated that the level of physical activity is low-
er in RA patients (1, 14, 18, 19). It may be of value in the management of RA to 
promote physical activity, for instance to reduce fatigue (12, 13, 20, 21). Besides 
that, physical activity has several other beneficial effects for people with RA, such 
as reduction of cardiovascular risk, increasing aerobic capacity, increasing mus-
cle strength, and reducing pain and disability (12, 22-24). To update the informa-
tion about fatigue and physical activity in RA patients compared to the general 
population and to collect information about how many RA patients and people 
of the general population comply to the recommendation of moderate-intensity 
aerobic physical activity for a minimum of 30 minutes on at least five days each 
week ,(1) we performed this study. In addition limitations to begin with a new 
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sport are assessed which may be helpful for the development of an activity pro-
gram to treat fatigue in RA.
The objectives of this study were 1) to compare the level of physical activity 
and the level of fatigue between RA patients and the general Dutch population 
and 2) to investigate whether self-reported physical activity depends on age, 
gender, BMI, and disease duration in RA patients, and 3) to describe which sport 
activities RA patients perform and which limitations RA patients experienced to 
participate in sports. 
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Methods
Design
Three different study populations were used: two RA populations and one sam-
ple from the general population. 
The first patient population consisted of 228 RA patients who visited the out-
patient clinic of the Radboud university medical center at Nijmegen in 2006 and 
2007. Information about patient characteristics and fatigue was collected using 
questionnaires that were filled out by the patients in 2006 and 2007.   
The second study population consisted of 771 RA patients who filled out an
online questionnaire between April 2013 and October 2014. Patients had been 
invited via 1) the website of the rheumatism foundation in the Netherlands and 
via a patient magazine and a newsletter especially for people with rheumatism, 
or 2) via their online electronic patient database called Rheumatology Online 
Monitor Application (ROMA). The questionnaire consisted of questions about 
patient characteristics (age, gender, BMI, disease duration) and physical activity 
(Short QUestionnaire to Assess Health enhancing physical activity (SQUASH)) and 
the RSO (the guideline for sport participation) about sport habits.
Data from the general Dutch population were obtained using a subset of par-
ticipants from the Nijmegen Biomedical Study (NBS). Details of the NBS have 
been described before (25). Briefly, the NBS is a population-based survey con-
ducted by the Department for Health Evidence and the Department of Labora-
tory Medicine of the Radboud university medical center. In 2002, 22451 age and 
sex stratified randomly selected inhabitants of the municipality of Nijmegen re-
ceived an invitation to fill out a postal questionnaire (NBS-1), including questions 
about lifestyle, health status, fatigue (Shortened Fatigue Questionnaire (SFQ)), 
and medical history, and to donate an 8.5 ml blood sample in a serum separator 
tube and a 10ml EDTA blood sample. A total of 9350 (43%) persons filled out 
the questionnaire, of which 6468 (69%) donated blood samples. After NBS-1, 
several additional NBS phases were initiated (NBS phase 2 to phase 5) in which 
participants of each phase were re-invited to participate in the next phase, pro-
vided that they did not object against participation in follow-up studies. In the 
current study, we included 3833 participants from the NBS that completed both 
the NBS-1 (including questions on fatigue; 2002) and NBS-5 (including questions 
on physical activity based on the SQUASH questionnaire; 2012). 
Fatigue
In the NBS, fatigue was assessed using a short version of the fatigue severity sub-
scale of the Checklist Individual Strength (CIS20), the Dutch ‘Shortened fatigue 
questionnaire’ (SFQ) (26, 27). The SFQ consists of the following four items, each 
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of which is scored using a 7 point Likert scale: ‘I feel tired’, ‘I tire easily’, ‘I feel fit’ 
and ‘I feel physically exhausted’. The SFQ has shown good internal consistency 
(Cronbach α=0.88) and was found able to discriminate between patients and 
healthy subjects (27). The total SFQ score has a range between 4 and 28, where-
by a higher score of the SFQ indicates a more severe level of fatigue. 
In both RA populations, fatigue severity was measured using the fatigue sev-
erity subscale (CIS-fatigue) of the Checklist Individual Strength (CIS20) (26). The 
CIS-fatigue consists of 8 items and all items are scored on a 7 point Likert-scale 
(range 8-56), asking about fatigue severity the last two weeks. The SFQ score was 
calculated from the 4 items of the CIS20, as described above. 
Physical activity
Physical activity was assessed using the SQUASH for both RA patients as for the 
general Dutch population. This Dutch questionnaire is a reliable and valid meth-
od to measure physical activity during one week (28). It contains ten questions 
divided over four categories: commuting, activities at work or school, household 
activities and leisure time activities. The respondents were asked to refer to an 
average week in the last month. Total amount of physical activity in minutes per 
week was calculated by multiplying the average time per day for each activity 
with its days per week, followed by summing the time per week of all the four 
categories. In addition, the percentage of persons who fulfill the recommen-
dation for daily physical activity was assessed. This recommendation from the 
American College of Sports Medicine and the American Heart Association rec-
ommended that all healthy adults aged 18 to 65 years need moderate-intensity 
aerobic physical activity for a minimum of 30 minutes on at least five days each 
week (1). 
The questionnaire filled out by the RA patients also contained the RSO (the 
guideline for sport participation) about sport habits. This standardized question-
naire consists of questions about sport frequency, the type of sport, the options 
for activities in the near environment, and the type of sport club. Furthermore, it 
contains questions about any activity restriction, advice regarding sports, history 
of exercise and possible interest in type of sport (29).
Statistical analysis
All variables were tested for missing values and outliers. An outlier was defined 
if the z-score of the absolute value > 3.29 and were imputed by single imputa-
tion. Single imputation was performed based on multiple linear regression for 
replacing missing values. Differences in age, gender and body mass index (BMI) 
between RA patients and the general Dutch population were analysed using an 
independent student t-test (continuous variables) or a Chi-square test (categori-
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cal variables) as appropriate. Differences in fatigue scores between both groups 
were tested using a Mann-Whitney U test. Differences in total physical activity 
in minutes per week were tested between both groups using a Mann-Whitney 
U test. Linear regression was performed in RA patients with physical activity as 
dependent variable and age, gender, BMI and disease duration as independent 
variables to investigate whether self-reported physical activity depends on these 
variables. Variables and residuals were tested for normality. Analyses were per-
formed with SPSS, version 20.0 (SPSS, Chicago, IL). Results are presented as me-
dian plus interquartile ranges unless stated otherwise. 
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Results
Of the 771 RA patients who started the online questionnaire, 740 RA patients 
filled out the questionnaire completely. The Nijmegen Biomedical Study (NBS) 
received 3833 questionnaires from the respondents who were invited in 2012 to 
fill out the NBS-5 questionnaire (response rate NBS-5 51%). Of these 3833 NBS 
participants who filled out questionnaires NBS-1 and NBS-5, 3764 participants 
were included in this study, because they completed questions on fatigue (NBS-
1) and physical activity (NBS-5).
Table 1. Characteristics of the study population*
RA patients
n=740
General Dutch 
population
n=3764
P-value
Patients characteristics Age, years, mean 
± SD
55.9 ± 11.5 52.1 ± 15.2 <0.001*
Female, number (%) 409 (55) 2025 (54)  0.488
Body mass index, kg/
m2 , mean ± SD
26.2 ± 4.7 25.0 ± 3.9 <0.001*
Physical activity in 
hours/week (SQUASH)
Total physical activity 24.6 (11.9-40.5) 33.0 (16.0-50.0) <0.001*
Commuting activities 0.0 (0.0-0.08) 0.0 (0.0-1.5) <0.001*
Activities at school 
or work
0.0 (0.0-20.0) 0.0 (0.0-24.3)  0.020*
Household activities 6.0 (0.7-14.0) 8.0 (3.0-16.0) <0.001*
Leisure time acti-
vities
5.5 (2.9-9.9) 7.3 (3.0-13.1) <0.001*
Sport participant Number (%) of sport 
participants
438 (59.2) 1980 (52.6)  0.001*
Number of hours/
week
2 (1-3.8) 3 (1.5-5) <0.001*
Physical activity norm Activity days/week 5 (2-7) 5 (3-7) 0.207
Meet physical activi-
ty norm, number (%)
383 (51.8) 2045 (54.3) 0.214
*Values are median plus interquartile ranges unless stated otherwise. *Significant at P ≤ 0.05
Patient characteristics
Patient characteristics of the included RA patients and the general Dutch popu-
lation are shown in Table 1. RA patients are slightly older and have a higher BMI 
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than the NBS subset, but the percentage of woman is similar. The median (IQR) 
disease duration of RA patients was 8 years (4-19). 
Fatigue
RA patients experienced significant (p<0.001) higher levels of fatigue (Figure 1) 
with a median score of 16 (11-22) on the SFQ compared to the general Dutch 
population who had a median SFQ score of 9 (6-15). 
Figure 1. Box plots of the SFQ score for fatigue are shown for the RA patients and the general Dutch 
Population (NBS subset). The bold horizontal bars indicates the medians, the end of the boxes indicates 
the quartiles. Whiskers indicates minimum and maximum values.
Physical activity
Overall, the percentage of missing values of the physical activity questions was 
low in the dataset: less than 7.1 % of the SQUASH questions were missing in the 
NBS data and less than 2.2 % for the RA patients. Total physical activity, commut-
ing activities, activities at school or work, household activities and leisure time 
activities were imputed by age, gender, BMI and not missing SFQ values. The 
missing SFQ values were imputed by age, gender and BMI and the not missing 
values of total physical activity, commuting activities, activities at school or work, 
household activities and leisure time activities.
With respect to the total amount of physical activity, RA patients were signifi-
cant less physically active compared to the general Dutch population, with a 
median of 24.6 (11.9-40.5) and 33.0 (16.0-50.0) hours per week respectively 
(p<0.001). RA patients spent less time per week in all four categories of physical 
activity (Table 1). At least once a week, 59% of the RA patients participated in 
sport, compared to 53% of the general Dutch population (p<0.001). However, the 
68 Chapter 4 
RA patients who participated in sport, spent significant less minutes per week in 
sport participation compared to the general Dutch population, 120 (60-225) and 
180 (90-300) minutes per week respectively (p<0.001). 
The median number of activity days, a day during which someone participate 
at least 30 minutes in moderate-intensity aerobic physical activity, is equal in 
both groups (5 (2-7) days in RA patients and 5 (3-7) days in the general Dutch 
population, p=0.207). Consequently, the percentage of people who meet the 
international guideline for physical activity did not differ in both groups (51.8% 
versus 54.3%, p=0.214). In RA patients, a lower level of physical activity was relat-
ed to an older age (β= -0.267, p<0.001) and  a longer disease duration (β= -0.167, 
p<0.001). There was a trend towards a higher BMI level (β= -0.070, p=0.058). 
Gender (β= -0.009, p=0.817) was not significantly associated with the level of 
physical activity. 
Sport habits of RA patients
From the 740 RA patients who filled out the SQUASH questionnaire completely, 
708 RA patients also filled out the RSO. At least once a week, 59% of the RA pa-
tients participated in sport with fitness, swimming, strength training and walking 
as the most popular sports. Of the 41% of the RA patients who did not partici-
pate in a sport most frequently mentioned reasons were: limitation in physical 
functioning, dependent on transport, lack of supervision of an expert. 
Only a small part of the patients experienced difficulties in participating in 
sport (6.8%). 38.2% of the RA patients filled out that they had received advise 
to start participating in a sport. Advice was most frequently given by medical 
specialists, followed by physiotherapists and general practitioners. Of the RA pa-
tients, 32% has interest to practice a new sport. However, most frequently men-
tioned limitations to begin with a new sport are physical impairment, not being 
aware of the options, and fear of injuries. 
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Discussion
According to the results of this study, RA patients showed lower levels of phys-
ical activity and higher levels of fatigue than the general population; the level 
of physical activity decreased with age and disease duration while there was no 
gender difference. At least once a week, 59% of the RA patients participated in 
sport with fitness, swimming, strength training and walking as the most popular 
sports.
RA patients were about eight hours per week less physically active compared
to the general Dutch population; RA patients indicated to be physically active 
for 25 hours a week on average, while this was 33 hours per week for the gen-
eral population. Interestingly, both half of the RA patients (52%) and half of the 
people from the general population (54%) were meeting the physical activity 
recommendation (1).  
The fatigue levels were significantly and considerably higher in the RA sam-
ple than in the sample from the general population. The SFQ however does not 
have a cut point for ‘severe’ fatigue as the CIS has (8). Therefore, we can say that 
RA patients have more fatigue than the general population, though it is difficult 
to say how many people have severe fatigue. 
Among RA patients who performed sports activities (50%), fitness training, 
swimming, strength training and walking were most frequently performed and 
appear to be most popular. Running, cycling and team sports were infrequently 
engaged in. Of the included RA patients, 32% have interest to practice a new 
sport. However, most frequently mentioned limitations to begin with a new sport 
are physical impairment, not aware of the options, and fear of injuries. 
These finding are according to a qualitative study about perceptions of the 
effects of exercise in RA patients (30). The results of physical activity level in 
this study are in line with those found in previous studies (14, 18, 31-34). When 
comparing the level of subjectively assessed physical activity between RA pa-
tients and controls, it appears in all studies that patients with RA show a lower 
level of physical activity compared to the control group(14, 31-34). Question-
naires were used to assess physical activity level. Objective assessment of physi-
cal activity level, e.g. using activity trackers, has its advantages above subjective 
assessments e.g. using questionnaires. However, objectively assessed physical 
activity has not been compared directly between RA patients and controls. When 
comparing different studies using objective assessment of physical activity level, 
it appears that indeed patients with RA are less physical active than the general 
population and more active than people with CFS (35). 
There is one previous survey (2007) similar to ours, in which physical activity
level was subjectively measured using the SQUASH in 252 patients with RA, com-
70 Chapter 4 
pared with reference values from the general population in The Netherlands 
(18). Fatigue however was not assessed. Regarding physical activity, similar re-
sults were found, including the finding that about half of the patients with RA 
and people from the general population fulfilled physical activity recommenda-
tions (18).  
Concerning fatigue levels, two smaller previous studies compared self-repor-
ted fatigue in RA patients with healthy controls and found significantly higher 
fatigue scores in patients with RA (5, 14). Fatigue was measured with the Fatigue 
Severity Scale (FSS) and with the Multidimensional Assessment of Fatigue (MAF), 
so results cannot be compared. However, it seems a consistent finding that RA 
patients are more fatigued than the general population. Few studies assessed 
sport participation and preferences of sports activities in RA (36-38). Differences 
were found in percentage of RA patients performing sport activities and a com-
parison between these studies cannot be made because of the different criteria 
of being physically active or being a sport participant (36-38). Most RA patients 
preferred exercising at home, alone, at moderate intensity, and the preferred 
type and most common type of exercise was walking (37).  
A limitation of this study was that fatigue was assessed differently in the stu-
dy populations that we compared. In the general population the SFQ was used 
for assessing fatigue, which was not available in the RA population. To compare 
fatigue levels in the general population with fatigue levels in the RA population 
we used data of another study population including RA patients of our medical 
center. However, no differences regarding patient characteristics were found be-
tween the two RA study populations, thus we assume that the smaller RA pop-
ulation is representative of the larger populations. Secondly, the proportion of 
females in the RA study population assessed for physical activity was about 50%, 
similar as in the general population, but usually the proportion of females in RA 
samples is 60%-80%. Gender was not associated with physical activity level so we 
regard that the results are generalizable tot other RA study populations.
While patients with RA have more fatigue and a lower level of physical acti-
vity, the question remains whether and how physical activity and fatigue are 
related: is there a causal relation and does one cause the other, or vice versa, or 
does both happen? In our previously performed study, we showed that the level 
of fatigue and the level of objectively assessed physical activity in RA are asso-
ciated: RA patients with more fatigue were less physically active (35). Hypothet-
ically, to break a vicious circle, increasing exercise could be effective to reduce 
levels of fatigue. Only one single RCT has been performed on aerobic exercise in 
RA with fatigue as dedicated primary outcome measure (20). In a meta-analy-
sis, the results of this RCT (20) combined with the results of four other RCT’s in 
which fatigue was measured but originally not reported (13), it is shown that an 
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aerobic exercise program is effective in reducing fatigue among patients with RA 
(13). However, the effects were small, and further research should be performed 
to make the evidence more clear. There is some evidence for several forms of 
activity or exercise that they may be effective in reducing fatigue in RA reported 
in meta-analysis (12, 21). There however is no evidence to prefer one mode of 
exercise over the other, nor is it clear what would be the most effective mode to 
deliver these interventions as well as how best to incorporate exercise into the 
lives of RA patients (39). Moreover, there are serious concerns about the degree 
of adherence to long term exercise (39, 40). To facilitate initiation of and adher-
ence to exercise, it is important to understand the perceptions of RA patients 
and health professionals about barriers and facilitators to exercise (30). These 
patient perceptions have also been studied using qualitative research and a sur-
vey (30, 37). It was found that the most relevant patient perceptions regarding 
exercise are: ‘Health professionals showing a lack of exercise knowledge’, ‘Not 
knowing what exercise should be done’, ‘Nothing can be done about managing 
fatigue’, ‘Not wanting to exercise as joints hurt’, ‘Worry about causing harm to 
joints’ and ‘Having to exercise because it is helpful’. Therefore, a patient-individ-
ualized exercise program could be a promising treatment for fatigue in RA.
If, in future, exercise also has proven to be effective for fatigue in a trial set-
ting, physical exercise can be implemented by a guideline for the inter-disciplinary 
treatment of fatigue in RA. For improving aerobic capacity, exercising should be 
performed between 50-90% of maximal heart rate according to the American 
College of Sports Medicine’s guideline (41). And, as aerobic capacity is a very 
central concept of physical fitness/human performance, there is good reason to 
hypothesise that improving aerobic capacity may reduce fatigue. As shown that 
supervised programs are more effective for inducing a significant improvement 
in aerobic capacity than home aerobic exercise (42, 43), and factors related to 
inactivity in RA were reduced self-efficacy for exercise (44), fear avoidance (45), 
lack of strong motivation (46, 47), we advise to bring patients to a certain level of 
aerobic conditioning by a short intensive phase of a supervised/coached exercise 
program. After the supervised exercise program, patients can maintain exercis-
ing using their preferred modes of exercise, such as (Nordic) walking, exercise 
at home, but also exercise at a regular sports center, exercise supervised by a 
therapist, or on an individual basis with an individual exercise program.
In conclusion, this study showed that the amount of minutes of physical acti-
vity per week was lower in RA patients compared to the general Dutch pop-
ulation. In RA, a lower level of physical activity was associated with older age 
and longer disease duration. The most preferred mode of sport participating in 
RA was fitness, swimming, strength training and walking. Most frequently men-
tioned limitations to begin with a new sport are physical impairment, not being 
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aware of the options, and fear of injuries. In addition, patients with RA reported 
a higher level of fatigue than the general population. First steps can be taken to 
develop an effective exercise program to treat fatigue in RA. RA patients should 
be encouraged to increase physical activity with as consequence a possible re-
duction in fatigue. Because adherence is a concern and the most effective mode 
is unclear, in future, a study of exercise for fatigue in RA patients having fatigue 
should be performed, using a coached graded activity program with continuous 
monitoring and feedback e.g. by using a commercially available activity tracker.
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Abstract
Objective 
Fatigue is one of the most commonly reported symptoms in rheumatoid arthri-
tis (RA). Many factors may play a causal role on fatigue in RA patients, but their 
contribution and interplay is barely understood. The objective was to develop a 
multidimensional model of factors that explain fatigue severity in RA.
Methods 
A cross-sectional study (n=228) of consecutive patients with RA was performed. 
Fatigue, disease characteristics and psychosocial and behavioral outcomes were 
collected. Baseline differences between non severely fatigued patients (CIS-fa-
tigue <35) and severely fatigued patients (CIS-fatigue ≥ 35) were tested. Structur-
al equation modeling was used to test a hypothesized model for fatigue. 
Results 
The final model includes pain, physical functioning, mood, sense of control, sleep 
quality and fatigue, with good fit (CFI=0.976) explaining 74% of the variance in 
RA fatigue. Accordingly, poor sleep quality (β=0.42, p<0.001) and less physical 
functioning (β=0.65, p<0.001) are directly related to a higher level of fatigue. 
Less sense of control is related to more mood disturbance (β=0.64, p<0.001), 
more pain (β=0.389, p<0.001) and less physical functioning (β=-0.24, p<0.001). 
More mood disturbance is related to poor sleep quality (β=0.78, p<0.001) and 
higher pain level is related to less physical functioning (β=0.75, p<0.001). 
Conclusion 
RA fatigue is directly influenced by poor sleep quality and physical functioning, 
and indirectly by sense of control, mood and pain. Treatment of these factors by 
psychological interventions and physical exercise could help to improve fatigue 
in patients with RA. 
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Introduction
Fatigue is a frequently reported symptom in rheumatoid arthritis (RA) (1) but its 
causes and their interplay are barely understood (2). Severe fatigue may occur in 
up to 40% of RA patients, even in patients with low and moderate levels of dis-
ease activity, who are reasonably well-treated regarding their RA (3). Currently, 
it is not clear which interventions are effective to treat RA fatigue. There is some 
evidence that psychological interventions as well as exercise may reduce fatigue 
in RA (4-6). Knowing which factors are associated with fatigue may guide choos-
ing effective treatment options (2). Inflammation, anemia and depressive dis-
order have long be held responsible for fatigue in RA. However, the prevalence 
of anemia and depression cannot explain the prevalence of severe fatigue in RA 
(7, 8). Although a positive association between disease activity and fatigue has 
been found (9-11), it appears that pain rather than inflammation is related to RA 
fatigue (1, 11-13). Consequently, the relation between inflammation and fatigue 
appears to be mediated through pain. 
Several cross-sectional studies showed that psychosocial factors, pain and li-
mitations in daily functioning, rather than inflammation, are related to fatigue 
severity in RA (1, 9-12, 14-18). It has been shown that self reported depressive 
symptoms are associated with RA fatigue (11, 12, 14, 18-20). Also, lower self-ef-
ficacy with respect to fatigue (11, 14, 18), a perceived lack of social support 
(11, 18), lower mental health (17), coping strategies like worrying and resting, 
catastrophizing of fatigue, low self-esteem, strong somatic fatigue attributions 
and less social functioning were related to higher fatigue in RA (14). Longitudi-
nal studies assessing fatigue over a period of one year showed that pain, daily 
functioning, and psychological factors such as self-efficacy and coping strategies 
were related to fatigue severity in RA (3, 21, 22). Physical functioning also seems 
an important variable associated with fatigue in RA: several studies showed that 
fatigue was closely related to activity limitations (1, 14, 17, 22, 23). However, 
how these factors together may contribute to fatigue in RA has been studied only 
once. This study of Nicassio et al. (2012) evaluated a multidimensional model 
using path analysis and found that disease activity contribute to fatigue through 
mood disturbance and poor sleep quality and that both disease activity and 
mood disturbance retained direct relationships with fatigue (24). Other possible 
relevant factors associated with fatigue in RA that were not regarded in that 
study (24) were, physical functioning (3, 9-11, 14, 17, 22, 25, 26), and sense of 
control (11, 14, 18) with respect to fatigue. Therefore, the objective of this study 
was to develop and test a multidimensional model of factors that determine 
fatigue severity in RA. Developing such a model of fatigue might facilitate the 
development of an effective treatment strategy for fatigue in RA. 
82 Chapter 5
Methods
Design
In this study, multidimensional path analysis modeling was applied using 
cross-sectional data on fatigue, disease characteristics and psychosocial and be-
havioral outcomes in consecutive patients with established RA (14, 26). Approval 
for this study was obtained from the Medical Ethics Committee Arnhem-Nijme-
gen in the Netherlands and all participants provided written informed consent.
Recruitment of patients
A total of 431 RA patients aged 18–75 years visiting their rheumatologist for a 
scheduled 3-monthly check up appointment at the outpatient clinic of the Rad-
boud University Medical Centre were asked to participate between June 2006 
and October 2007. Patients received written information about the study and 
were informed orally by their rheumatologist or nurse specialist. Inclusion cri-
teria were: diagnosed with RA according to the 1987 ACR classification criteria, 
between 18 to 75 years of age and able to read and write Dutch. Patients were 
not included if they had a second rheumatic disease, a history of malignancies 
or other co-morbidities associated with chronic fatigue or if they had a current 
diagnosis of depression and/or current psychological or psychiatric treatment. 
Study participation was allowed with the following comorbidities (well con-
trolled): regulated thyroid disease, a controlled diabetic mellitus, a mild non-re-
strictive chronic obstructive pulmonary disease and a successfully treated not 
metastasized basal cell carcinoma or squamous cell carcinoma in the skin. 
Data collection
Patient characteristics (gender, age, body mass index (BMI)), disease character-
istics, (pain, disease duration, rheumatoid factor) and medication use were col-
lected at inclusion by research nurses. Blood samples were taken to determine 
ESR, CRP and hemoglobin level, and disease activity was assessed by the rheu-
matologist or a specialized rheumatology nurse, by using the disease activity 
score (DAS28). Fatigue was collected at baseline using a patient questionnaire. 
The following psychosocial and behavioral variables that might influence fatigue 
were collected: mood disturbance, sense of control over fatigue, poor sleep 
quality and physical functioning by using patient questionnaire.
Fatigue 
Fatigue severity was measured using the fatigue severity subscale (CIS-fatigue) 
of the Checklist Individual Strength (CIS20) (27). The CIS-fatigue consists of 8 
items and all items are scored on a 7 point Likert-scale (range 8-56), asking about 
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fatigue severity the last two weeks. Higher scores indicate a higher level of expe-
rienced fatigue. A score of ≥ 35 indicates severe fatigue. The CIS fatigue severity 
subscale has proven to be a reliable and valid instrument in numerous conditions 
and was also used in RA (14, 27). The internal consistency of the CIS-fatigue 
severity subscale by Cronbach’s alpha was 0.88 (27). Fatigue was also assessed 
using the vitality scale of the SF-36 consisting of four questions about vitality 
and fatigue with a range between 0-100, where higher scores indicate a higher 
level of vitality which is regarded as a lower level of fatigue. Cronbach’s alpha 
was 0.74 (28). 
Pain 
Pain severity was assessed using the Bodily Pain subscale of the Short Form 
Health Survey (SF-36-BP) and a visual analogue scale (VAS) assessing current 
pain severity (range 0 (no pain) to 100 (violent pain)). The SF-36-BP asks about 
pain and interference by pain during the last four weeks (29), (range 0-100) with 
higher scores indicating less pain. Cronbach’s alpha was 0.86 (28).
Physical functioning
Physical functioning was assessed using the SF-36 subscales physical function-
ing and role functioning (29). The total score ranges between 0-100 with higher 
scores indicating better physical functioning or role functioning. Cronbach’s al-
pha of SF-36 subscale physical functioning and role functioning were 0.90 and 
0.78 respectively (28). 
Mood disturbance
Self-reported depressive symptoms were assessed with 16 statements of the 
Symptom Check List 90 (SCL90) (30). The SCL depression consists of a 5-point 
likert scale ranges between 16-80. Higher scores indicate the presence of more 
(severe) depressive symptoms. Cronbach’s alpha was 0.91 (30).
Anxiety was assessed with 10 statements of the Symptom Check List 90 (SCL90) 
(30). The SCL anxiety consists of a 5-point likert scale ranges between 10-50. 
Higher scores indicate more (severe) anxiety. Cronbach’s alpha was 0.87 (30). 
Sense of control
Sense of control about fatigue was assessed using the Self-Efficacy Scale 28 
(SES28), a 7-item questionnaire scored on a 4-point Likert Scale (31) ranges be-
tween 7-28. Higher scores on the SES indicate more self-efficacy. Cronbach’s-α 
ranges between 0.68 and 0.77 (32, 33). Helplessness of fatigue was assessed 
with the subscale helplessness of the Fatigue Catastrophizing Scale (FCS). The 
FCS is the same questionnaire as the Pain Catastrophizing Scale, (34) in which 
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the word pain is replaced by fatigue. Higher score on the scale indicates a higher 
tendency to be helplessness in response to fatigue. The Cronbach’s-α of the FCS 
helplessness tested in our study sample was 0.85.
Sleep quality
Poor sleep quality was assessed by the subscale sleep disturbance (3 items) of 
the Symptom Check List 90 (SCL90) (30). The SCL90 consists of a 5-point Likert 
scale. Total score ranges between 3-15 with higher scores indicating more sleep 
problems. Cronbach’s- α was 0.80 (30).
Statistical analyses 
To test for differences between non severely fatigued patients (CIS-fatigue <35) 
and severely fatigued patients (CIS-fatigue ≥ 35 ) (based on Vercoulen (27)), a 
chi-square test, unpaired t-test or a Mann-Whitney U test was used as appro-
priate (Table 1). Structural equation modeling (SEM) is a statistical technique 
for testing hypothesized patterns of directional and non-directional relationships 
(‘path analysis’) among a set of observed (measured) and unobserved (latent) 
variables. 
First the model of Nicassio (24) was tested in our data of RA patients. This
model included constructs of disease activity, mood disturbance, sleep quality 
and fatigue (Figure 1). The model was assessed using multiple fit criteria: the 
comparative fit index (CFI), the standardized root mean residual (SRMR) and the 
root mean square error of approximation (RMSEA). The criteria of an SRMR < 
0.09 and a RMSEA < 0.06 is considered optimal to minimize the rates of type I 
and type II error (35, 36). The RMSEA is a measure of the degree to which the 
model holds in larger samples. Values up to 0.05 indicate a close fit in larger pop-
ulations. A CFI value of >0.90 is an indication of a good fitting model (36). The 
explained variance of the latent variable fatigue was analyzed by the R squared 
measure of goodness of fit. 
Figure 1. NICASSIO P. M. et al: A Multidimensional Model of Fatigue in Patients with Rheumatoid Arthri-
tis. J Rheumatol. 2012; 39(9): 1807–1813
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After testing the model of Nicassio (24) in our data, a hypothesized model for 
fatigue was further developed (Figure 2). This hypothesized model was based on 
the model of Nicassio et al. in which pain (as a measure of disease activity), mood 
and poor sleep quality are relevant (24) and the model of the chronic fatigue 
syndrome of Vercoulen et al. in which sense of control is an important factor. 
Thereby our previous study showed that physical functioning is related to RA fa-
tigue, more active RA patients showed less fatigue than passive RA patients (37). 
We therefore included these variables for RA fatigue in our hypothesized model; 
which accordingly included constructs of pain, physical functioning, mood, sense 
of control, sleep quality and fatigue. We included VAS pain and SF-36 bodily pain 
as indicators for the latent variable pain. Physical functioning was included as a 
latent variable in the model with 2 indicators representing SF-36 physical func-
tioning and SF-36 role functioning. Mood disturbance was included as a latent 
variable with 2 indicators representing depressive thoughts (SCL90 depression) 
and anxiety (SCL90 anxiety). Sense of control was included as a latent variable 
with 2 indicators representing helplessness (FCS-helplessness) and self-efficacy 
(SES28). Poor sleep quality was included as a latent variable with 1 indicator rep-
resenting SCL90 sleep quality. Finally, fatigue was included as the latent variable 
in the model with 2 indicators representing the CIS fatigue and the SF-36 vitality 
(Figure 2). Analyses were performed using SPSS 20.0 and MPlus (version 6.0).
Figure 2. Our hypothesized model with included latent variables.
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Results
A total of 230 patients were included. Two patients were excluded after the mea-
surements because of a sleep apnoea and a malignant lung tumour, thus 228 pa-
tients were included in the analyses (Table 1). The mean age was 55.9 years, 63% 
was female and overall the majority had a low disease activity and a moderate 
fatigue level (27). At baseline, 36% received a tumor necrosis factor-inhibiting 
agent, either as monotherapy or in combination with a DMARD. Most disease 
related and other variables, including pain, physical functioning, mood distur-
bance, sense of control and sleep quality were all significantly different between 
severely fatigued patients and non severely fatigued patients at baseline (Table 
1).
Table 1. Baseline characteristics of all included variables*
Variables All 
patients 
(n=228)
CIS-fatigue < 
35  at baseline 
(n=132)
CIS-fatigue ≥ 
35 at baseline 
(n=96)
P-value
Patient 
characteristics
Age 55.9 (10.8) 58.06 (10.0) 52.95 (11.21) <0.001
Gender, women (%) 63 58 70 0.08
BMI 25.5 
(23.3-27.9)
25.7 
(23.1 – 27.8)
25.3 (23.4 
-28.4)
0.73
Medication 
use
DMARD monothera-
py (%)
63.6 68.2 57.3 0.09
MTX monotherapy 
(%)
36.4 39.4 32.3 0.27
DMARDs  ≥2 (%) 13.2 13.7 12.5 0.80
Biological use (%) 35.5 34.8 36.5 0.80
Oral prednisone (%) 13.2 12.9 13.5 0.88
Disease rela-
ted variables
Rheumatoid factor, 
+ (%)
74.9 82 66 0.02
Illness duration, 
years
11 (6-17) 11 (7-17) 10 (5-17) 0.15
DAS 28 (0-10) 3.2 (1.3) 2.9 (1.8) 3.7 (1.3) <0.001
SJC 28 (0-28) 4 (2-7) 3 (1-6) 4 (2-8) 0.009
TJC 28 (0-28) 2 (0-4) 1 (1-3) 3 (1-6) <0.001
VAS GH (0-100) 31.8 (21.5) 24.4 (16.9) 41.9 (23.0) <0.001
ESR, mm/h 8 (4-17) 9 (4-19) 7 (4-16) 0.89
CRP, mg/l † 0 (0-8) 0 (0-6) 0 (0-11) 0.04
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Variables All 
patients 
(n=228)
CIS-fatigue < 
35  at baseline 
(n=132)
CIS-fatigue ≥ 
35 at baseline 
(n=96)
P-value
Haemoglobin, 
mmol/l
8.2 (0.70) 8.2 (0.7) 8.2 (0.7) 0.60
Fatigue CIS-fatigue baseline 
(8-56)
31.5 (12.8) 22.4 (7.7) 44.1 (6.1) <0.001
SF-36 vitality (0-100) 56.8 (20.2) 68.0 (14.4) 41.4 (16.6) <0.001
Pain VAS pain severity 
(0-100)
31.1 (21.9) 24.8 (18.1) 39.7 (23.8) <0.001
SF-36 bodily pain 
(0-100)‡
64.2 (19.8) 72.7 (16.9) 52.5 (17.6) <0.001
Physical func-
tioning
SF-36 physical func-
tioning (0-100)‡
59.6 (24.4) 69.1 (21.8) 46.6 (21.7) <0.001
SF-36 role functio-
ning (0-100)‡
45.39 
(40.31)
62.31(38.4) 22.14 (30.1) <0.001
Mood distur-
bance
SCL 90 depressive 
thoughts (16-80)
21 (17-24) 18 (17-21.8) 23 (20-28.8) <0.001
SCL 90 anxiety 
(10-50)
11 (10-14) 10.5 (10-13) 13 (11-15.8) <0.001
Sense of 
control
SES 28 (7-28) 19.5 (3.5) 20.6 (3.1) 18.3 (3.5) <0.001
FCS-helplessness 
(0-24)
3 (0.3-6) 2 (0-5) 4 (1-8) <0.001
Sleep quality SCL90 sleep quality 
(3-15)
5 (3.3-8) 5(3-6) 7 (4-9.8) <0.001
* Numbers are mean (SD) , Median (P25-P75) or n (%) as denoted. ‡ scored on a reversed scale, a 
higher score means better functioning and less pain. DMARD: disease-modifying antirheumatic drug, 
MTX: methotrexate, DAS28: Disease Activity Score of 28 joints, SJC28: Swollen Joint Count of 28 joints, 
TJC28: Tender Joint Count of 28 joints, ESR: Erythrocyte Sedimentation Rate, CRP: C-Reactive Protein. 
CIS-fatigue: Checklist Individual Strength of fatigue, SF-36: Short Form Health Survey 36, SCL-90: 
Symptom Check List 90, SES: Self Efficacy Scale, FCS: Fatigue Catastrophizing Scale.
Model for fatigue
All data were screened for normality and there were no outliers. Testing the 
model of Nicassio et al. in our data resulted in a low model fit: a CFI of 0.82; 
RMSEA was 0.193 and SRMR was 0.166. This indicates that this model does not 
fit well in our data.
Next we tested our hypothesized model which revealed an indirect path 
from pain to fatigue through mood disturbance and poor sleep quality. Both sense 
of control and physical activity retained direct relationships with fatigue. The fit 
(CFI) of the hypothesized model was 0.936, RMSEA=0.095 and SRMR=0.084.  
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The modification indices of the SEM test indicated that an extra path from 
sense of control to mood disturbance would have a significant positive effect 
on the model fit. There was also a significant positive effect of pain on physical 
functioning. The path from pain to mood disturbance and the path from sense of 
control to fatigue were not significant and were removed. Thereby an extra path 
from sense of control to pain and a direct path to physical functioning would 
gave a better fit. Finally, the revised final model provided a better fit to the data. 
Figure 3 showed the final model with standardized correlation coefficients and 
Table 2 the unstandardized and standardized coefficients between the latent vari-
ables of the final model. The CFI of the final model was 0.976; RMSEA was 0.058 
and SRMR was 0.043. Results of Figure 3 and Table 2 show that poor sleep quality 
(β=0.42, p<0.001) and less physical functioning (β=-0.65, p<0.001) are related to 
a higher level of fatigue in RA. Thereby,  less sense of control (more helplessness 
and less self-efficacy) is related to more mood disturbance (β=-0.64, p<0.001). 
More mood disturbance is related to poor sleep quality (β=0.78, p<0.001) which 
is related to a higher level of fatigue. In addition, a higher pain level is related to 
less physical functioning (β=-0.75, p<0.001) which is related to a higher fatigue 
level. Thereby less sense of control is related to more pain (β=0.39, p<0.001) and 
less physical functioning (β=-0.24, p<0.001) The R square was 0.74 which means 
that the model explained 74% of the variance in fatigue in RA. 
Figure 3. The final model with standardized correlation coefficients. SF-36: Short Form Health Sur-
vey 36, SCL-90: Symptom Check List 90. VAS: visual analogue scale, CIS: Checklist Individual Strength. 
* p<0.001. The latent variables are shown in rounds and the constructs of the latent variables are 
shown in squares.
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Table 2. Path coefficients of the final structural equation model*
Effects Unstandar-
dized
SE P-value Standardized
Poor sleep quality → fatigue 3.881 0.789 <0.001 0.419
Physical functioning → fatigue -0.641 0.076 <0.001 -0.648
Pain → physical functioning -1.087 0.168 <0.001 -0.752
Sense of control → mood distur-
bance
-1.249 0.162 <0.001 -0.638
Mood disturbance → poor sleep 
quality
0.220 0.028 <0.001 0.781
Sense of control → physical 
functioning
1.244 0.442 <0.001 0.241
Sense of control → pain -1.391 0.367 <0.001 -0.389
*Unstandardized means that the coefficients are uncorrected for differences in scaling. SE: standard 
error. Standardized means that the coefficients are corrected for scale differences to facilitate compa-
rison.
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Discussion
According to the multidimensional path analysis model developed in this study, 
RA fatigue is influenced directly by poor sleep quality and physical functioning, 
and indirectly by sense of control, mood, poor sleep quality and pain. This means 
that poor sleep quality and a lower physical functioning are directly associated 
with a higher fatigue level. Indirectly, more pain was associated with less physical 
functioning; more mood disturbance was associated with poor sleep quality, and 
less sense of control was associated with more mood disturbance, more pain 
and less physical functioning. The model explained about three quarters of the 
variance in fatigue in RA. 
A multidimensional model of fatigue for patients with RA was tested in only
one other study (24). According to that model, higher levels of disease activity, 
mood disturbance and poor sleep quality had direct and indirect effects on fa-
tigue, explaining 62% of the variance in fatigue (24). However this model did not 
fit well in our sample of RA patients, although it is clear that models generally 
perform somewhat worse in external data. Nevertheless, we tried to make a bet-
ter fitting model with inclusion of psychosocial factors and physical functioning 
besides pain, mood disturbance and sleep quality. Notably, another explanation 
for the relatively poor fit of Nicassio’s model in our RA sample could be the dif-
ferent use of measurement instruments, besides sample differences. The model 
we developed explained 74% of the variance in fatigue, which is quite well.
In several studies it has been analyzed which disease-related and/or psycho-
social variables are associated with fatigue (3, 13, 21, 22). These studies provid-
ed evidence that disability (3, 22), lower self-efficacy (21), sleep disruption and 
depressed mood (21), and more trait anxiety (22) were associated with future 
fatigue in RA. A recent systematic review concerning factors related to fatigue in 
RA, concluded that three variables have a high probability to be involved in the 
complex process of fatigue in RA: pain, disability and depressive mood, while 
more evidence was found for fatigue being related to pain and physical function 
than to depression (13). The factors in the model of our study are in line with this 
review. Our findings suggest that fatigue in RA is directly associated with physical 
functioning and poor sleep quality and indirectly by pain, sense of control and 
mood disturbance. 
A limitation of our study is that using SEM in a cross-sectional design no de-
finitive cause-effect relationship can be determined. Cause-effect relations can 
best be studied using a randomized controlled trial or a longitudinal design. An-
other limitation is the total number of patients included, which limits the num-
ber of variables that can be included in the model. As measures of physical func-
tion we used patient questionnaires: SF-36 physical functioning and SF-36 role 
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functioning, which were also used in the previous studies. Patient questionnaires 
represent perceived activity, rather than objectively measured activity. However, 
inclusion of objectively assessed actometer scores that were available in a large 
subset of the patients did not change the model nor the model fit (data not 
shown). Another limitation is that we could not validate our model because of 
the sample size. To validate our treatment model and to facilitate generalization, 
it should be tested in another sample of RA patients. 
Developing a model of fatigue might facilitate the development of a treat-
ment strategy for fatigue in RA. The five factors: pain, mood disturbance, sense 
of control, sleep and physical functioning, found in our study are perpetuating 
factors of fatigue and this is interesting for fatigue treatment. If these factors 
could effectively be treated, this may lead to improvement in patients’ fatigue. 
Pain in RA is treated with anti-rheumatic medication and pain-medication (38). 
However, pain treatment alone is insufficient to treat fatigue as fatigue frequent-
ly occurs in patients with low or moderate disease activity (3). 
Psychological interventions, notably CBT, can be used for improving sense 
of control and mood and as consequence a better sleep quality. Studies of Hew-
lett and Evers indicated that CBT improves fatigue impact, coping and perceived 
severity and well-being in RA (5, 39). Stimulus control instructions, and sleep 
restriction have proven to be effective in other sleep-disordered populations 
(40, 41). Little has been reported on the effectiveness of CBT in reducing sleep 
disturbances in patients with RA (42) although a study found improvements in 
subjective sleep quality after CBT (43). A recent yet incompleted trial is investi-
gating the effect of intermittent aerobic exercise on the improvement of sleep 
in patients with rheumatoid arthritis (44), however the effect is not known yet. 
Alternatively, an exercise program to increase the level of physical activity (func-
tioning) could be effective in reducing fatigue. Several RCT’s and a meta-analysis 
provided evidence that several types of physical activity provide benefit for fa-
tigue in adults with RA (4).
In summary, according to our model, RA fatigue is influenced by pain, sleep
quality, sense of control, mood and physical functioning. This suggests that treat-
ments aimed at these five factors could help to reduce fatigue in RA. Treatment 
studies, especially RCT’s, are needed to test the efficacy of these interventions. 
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Abstract
Objective 
Rheumatoid arthritis (RA) fatigue is not being well-managed currently and ev-
idence about effective interventions is limited. Aerobic exercise may provide 
benefit to treat fatigue in RA. Therefore, the purpose of this meta-analysis is to 
analyze the effect of aerobic land-based exercise on fatigue in RA. 
Methods 
A literature search was conducted using Pubmed, Cochrane library, Embase and 
trial registers to identify randomized controlled trials (RCTs) with a supervised 
land-based aerobic exercise program performed with an intensity between 50-
90% of maximal heart rate, of at least 15 minutes duration, performed at least 2 
times a week, and lasting for a time period of at least 4 consecutive weeks. Risk 
of bias was assessed using the Cochrane tool. Meta-analysis of fatigue outcomes 
was performed by calculating the standardized mean difference (SMD) using a 
random effects model.
Results 
Five RCT’s could be included. None of the trials selected patients with RA for 
having fatigue. Risk of bias was low in three RCTs and unclear in two. Land-based 
aerobic exercise programs had a positive effect on fatigue in RA compared to no 
exercise at 12 weeks, SMD (95%CI) =-0.31 (-0.55, -0.06). At 24 weeks, the effect 
of aerobic land-based exercise was smaller and not statistically significant, SMD 
(95%CI)=-0.15 (-0.33, 0.02). 
Conclusion 
There is evidence with low risk of bias that an aerobic exercise program is ef-
fective in reducing fatigue among patients with RA, especially in the short term, 
however effects are small. To substantiate the evidence, RCT’s should be per-
formed in patients with RA selected for having fatigue.
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Introduction
In rheumatoid arthritis (RA), fatigue is a frequent complaint, even among pa-
tients with low and moderate levels of disease activity (1, 2). As much as 40% of 
the patients with RA may be severely fatigued, having fatigue levels similar to pa-
tients with the chronic fatigue syndrome (CFS) (1). Indeed, fatigue in RA is a pa-
tient-relevant complaint: patients with RA express their fatigue as unpredictable, 
overwhelming and different from normal tiredness (2) and it is often perceived 
as debilitating and restricting daily functioning (1, 3-5). Potentially, fatigue in 
RA has a large impact on quality of life and patients give high priority to reduce 
fatigue (6). RA fatigue is associated with multiple factors: disease related factors 
(pain, joint damage, disability), cognitive and behavioral factors (anxiety, depres-
sion, illness beliefs and stress) and personal factors (work/caring responsibilities, 
environment, health, lost social support) (7).
However, currently RA fatigue is not being well-managed. Lack of knowledge
about the causes of fatigue as well as lack of knowledge of effective treatments 
may contribute to fatigue being neglected during patient-physician contacts (2, 
8). Most rheumatologists pay attention to fatigue during the first consultation 
and less often during follow-up consultations (8). Clinicians may tend to assume 
that the patient will raise the issue. Having effective interventions for the treat-
ment of fatigue in RA is of major importance, but evidence regarding effective 
interventions still is limited. Similar to the CFS (9, 10), in RA most evidence is 
available for the effectiveness of cognitive behavioral therapies (CBT) and exer-
cise (11-16). 
The underlying mechanism of fatigue in RA is not known. Previous research
supports that psychological factors, pain, physical activity, but not the level of 
inflammation are related to fatigue in RA (7, 17, 18). Physical functioning as well 
as activity level may play a role in maintaining fatigue levels in RA (19); a higher 
level of daily physical activity was associated with reduced levels of fatigue. It 
is well known from several randomized controlled trials (RCT) in RA that short-
term and long-term exercise programs are beneficial to reduce pain and disabil-
ity and that exercise can be performed safely (20). However, regarding fatigue 
the evidence is less clear. Systematic reviews indicate that there is evidence to 
suggest that several exercise forms provide benefit to treat fatigue in RA (15, 
16). As aerobic capacity is a very central concept of physical fitness/human per-
formance, there is good reason to hypothesise that improving aerobic capacity 
may reduce fatigue. However, only one single RCT has been performed on aer-
obic exercise in RA with fatigue as dedicated primary outcome measure (14). In 
that trial, fatigue decreased significantly for the exercise group compared to the 
control group (14). To summarize the limited evidence of the effect of an aerobic 
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exercise program on fatigue and to get a better estimate of the mean effect, we 
performed the current meta-analysis. The purpose of this meta-analysis of RCTs 
was to analyze the short-term (≤12 weeks) as well as the long-term (24 weeks) 
effect of land-based aerobic exercise programs on fatigue in RA, including pub-
lished and unpublished fatigue data. In addition, the relation between the effect 
of the intervention and baseline fatigue and the relation between the effect of 
the intervention and disability were analyzed. 
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Methods
Design
A literature search was conducted using the electronic databases Pubmed, Co-
chrane library, Embase and three trial registers to identify RCTs comparing aer-
obic exercise versus no exercise in RA, regardless of whether fatigue outcomes 
were published. All authors were approached with a request to provide data on 
fatigue. Risk of bias of each RCT was assessed using the Cochrane Collaboration’s 
tool for assessing risk of bias (21). Meta-analysis of fatigue outcomes was per-
formed by calculating the standardized mean difference using a random effects 
model.
Inclusion criteria
RCT’s were included if the following inclusion criteria were met: 1) inclusion of 
patients with RA according to the ACR classification criteria; 2) supervised land-
based (bicycle or running or circuit training) aerobic exercise program; 3) the 
intervention is between 50-90% of maximal heart rate according to the Ameri-
can College of Sports Medicine’s guideline for improving aerobic capacity (22); 
4) training sessions were at least 15 minutes for at least 2 times a week, during 
at least 4 consecutive weeks (22); 5) the study was randomized; 6) the control 
group did not perform exercise. Supervised land-based aerobic exercise was 
chosen as an inclusion criteria because this includes most established aerobic 
training methods that are easy to implement in different forms (cycling, walking, 
‘aerobics’) and training intensity can be well regulated. Generally, supervised 
programs are more effective for inducing a significant improvement in aerobic 
capacity than home aerobic exercise (23, 24). Fatigue was not among the inclu-
sion criteria, because we also wanted to include studies in which fatigue data 
happened to be collected but were not reported. 
Search strategy
A systematic search of Pubmed, Embase and the Cochrane library database was 
performed in April 2014 for relevant RCTs from 1985 till April 2014, and the 
search strategies are shown in Table 1. 
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Table 1. Search strategies in Pubmed, Embase and the Cochrane library.
Database Search strategy
Pubmed (“Arthritis, Rheumatoid”[Mesh] OR rheumatoid arthritis[all fields]) AND ((“Exerci-
se”[Mesh] OR “Exercise Therapy”[Mesh] OR exercise*[all fields] OR training[all fields] 
OR intervention[all fields] OR programs[all fields] OR program[all fields] OR pro-
gramme[all fields] OR programmes[all fields] OR rehabilitation[mesh] OR rehabilita-
tion[subheading] OR rehabilitation[all fields] OR activity[all fields]) AND (aerobic*[all 
fields] OR dynamic[all fields])) AND (((randomized controlled trial [pt] OR controlled 
clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR drug therapy [sh] OR 
randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals [mh] NOT humans 
[mh])) OR “Meta-Analysis” [Publication Type] OR metaanalysis[tw] OR meta-analy-
sis[tw] OR meta analysis[tw] OR systematic[sb]).
Embase ‘rheumatoid arthritis’.ti,ab,kw. or rheumatoid arthritis.sh. and (exercise or ‘exerci-
se therapy’).sh. or exercise.af. or training.af. or intervention.af. or program*.af. or 
rehabilitation.af. or activity.af. and (aerobic or dynamic).af. Search strategy limited to 
randomized controlled trials.
Cochrane “rheumatoid arthritis” OR Arthritis, rheumatoid [Mesh] AND exercise [Mesh] OR 
exercise therapy [Mesh] OR exercise OR training OR intervention OR program OR 
programme OR rehabilitation OR activity AND aerobic OR dynamic. Search strategy 
limited to trials.
Further, the clinical trial registers at www.clinicaltrials.gov and www.trialregister.
nl and www.clinicaltrialsregister.eu were searched (Figure 1).
Selection
After screening title and abstract by two of the authors (SR and MF) the articles 
appearing to be relevant were read full-text and inclusion/exclusion criteria were 
applied (SR supervised by JF). The first or last authors of all included studies were 
approached by e-mail to ask whether they had collected any fatigue question-
naires such as the Bristol Rheumatoid Arthritis Fatigue Multi-dimensional Ques-
tionnaire (BRAF MDQ), Checklist Individual Strength (CIS20R), Fatigue Severity 
Scale (FSS), Functional Assessment Chronic Illness Therapy Fatigue (FACIT-F), 
Multi-dimensional Assessment of Fatigue (MAF), Short Form 36 vitality subscale, 
or a Visual Analogue Scale of fatigue (VAS), that was not reported in their pub-
lished article. 
Data extraction
Data on fatigue measures were extracted for the intervention group and the 
control group, at baseline and follow-up. Standard tables were used for data ex-
traction by one of the authors (SR supervised by JF).
The effect of aerobic exercise training on fatigue 103
1
2
3
4
5
6
Study quality assessment
Two authors (SR and JF) independently assessed the methodological quality of 
each study using the Cochrane Collaboration’s tool for assessing risk of bias (21). 
The risk of bias tool covers nine items within six domains of bias: selection bias, 
performance/detection bias, attrition bias, reporting bias and other bias (Table 
3). There were 3 rating categories available for each item: 1) low risk of bias: 
which is unlikely to alter the results seriously, 2) unclear risk of bias: bias that 
raises some doubt about the results, 3) high risk of bias: bias may alter the re-
sults seriously. All selected articles were scored by the two authors. Discordant 
judgments were resolved by discussion until consensus was reached.
Analysis
The effect of an exercise program on fatigue versus no exercise was assessed for 
each individual study by calculating the weighted standardized mean difference 
(SMD) and 95% confidence interval of the experimental group versus the control 
group. Individual SMD of all included studies were pooled using the inverse vari-
ance method (25). This was performed for both the short-term (≤ 12 weeks) and 
long-term (24 weeks) effects of exercise on fatigue. Heterogeneity of treatment 
effects among studies was statistically investigated using the I2 statistic. The de-
gree of heterogeneity was graded as low (I2< 25%), moderate (I2=25%-75%) or 
high (I2> 75%) (26). A random effects model was used to pool the studies. Sensi-
tivity analyses were performed regarding risk of bias (low versus other); fatigue 
data published (yes versus no) and length of supervised part of exercise program 
(short: ≤ 12 weeks versus long:24 weeks). Meta-regression analyses were per-
formed to analyze the relation between baseline fatigue (standardized as per-
centage of maximum possible score) and the effect of the intervention (SMD), 
and to analyze whether there was a relation between the effects on disability 
(disability index of the Health Assessment Questionnaire) with the effects on 
fatigue (SMD). In these analyses the RCTs were weighted according to study size.
The meta-analyses were done using Review Manager 5 and the meta-regression 
was performed using SPSS 20.0. 
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Results
Included studies
There were 232 articles identified by the search strategy, of which 86 were dupli-
cates. After screening 146 unique articles on title/abstract, 38 titles were consid-
ered relevant for reading full-text (Figure 1). Nineteen studies of the 38 met the 
inclusion criteria and the other 19 studies were excluded. Reasons for exclusion 
were: the study was not randomized (9 studies), duration of the intervention was 
less than 4 weeks (1 study), control group performed any form of aerobic exer-
cise (home-based) (2 studies), intervention was a water-based exercise program 
(1 study) or strengthening exercise (1 study) or dance-based exercise (not at 50-
90% of maximal heart rate) (1 study), the training intensity was not provided (2 
studies), the training was not supervised (2 studies). 
Of the 19 included studies, only one study reported fatigue as a primary out-
come measure (Neuberger 2007). Primary outcomes of the other included stud-
ies were disease activity, radiographic damage of the large joints, pain, depres-
sion, functional ability, cardiorespiratory fitness, and cardiovascular disease. 
Three studies were from the same research group (Neuberger) and with the 
same study population. Consequently, 16 authors were approached and respons-
es were received from 13 authors. In 5 studies fatigue data had been collected 
and these data were all retrieved (Figure 1). 
Also the corresponding investigators of three study protocols found in the 
trial registers were approached for fatigue data (NCT number: NCT00792675, 
NCT01553305,NCT01966835). Only one study (NCT01553305) collected fa-
tigue data, but this study was excluded because the control group performed a 
(self-administered) exercise program.  
Characteristics of included studies
The characteristics of the included studies are shown in Table 2 (14, 27-30). The 
smallest study included 34 patients (Reid 2011), the largest study (de Jong 2003) 
included 298 patients. 
The interventions included cycling, running or circuit training for at least 15 
consecutive minutes with a frequency of 2 or 3 times a week. The length of the 
supervised training programs differed between 4 weeks (van den Ende 2000) 
and 104 weeks (de Jong 2003). However, all studies collected fatigue data at 24 
weeks after baseline. In three studies the MAF was used as fatigue scale, in one 
study the SF-36 vitality subscale was used and one study used a VAS fatigue scale 
(Table 2).
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Figure 1. Flow chart search strategy
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Adherence to the exercise program. 
The way adherence was reported differed highly between the included studies. 
In the study of Van den Ende (29) the mean (SD) number of completed exercise 
sessions was 16 (9); one patient in the intervention group and one patient in the 
control group were lost to follow-up at 3 weeks of exercise. In the study of De 
Jong (28), 118 (81%) patients still participated in the exercise class after 2 years; 
no other data were reported. Median amount of exercise sessions followed in 
the class exercise group of the study of Neuberger (14) was 83%. The mean at-
tendance rate for the study of Reid (30) at the 8 week gym group sessions was 
78%. At 24 weeks, telephone interviews had been conducted and a large majori-
ty of participants (82%) responded that they did not continue with their exercise 
program, which was mainly attributed to a lack of access to suitable facilities and 
a lack of motivation (30). Mean attendance rate for the study of Stavropoulos-Ka-
linoglou (27) was 88% for the training group.
Study quality assessment
Blinding of participants and personnel, and blinding of the outcome assessment 
was not present for the fatigue outcome in any included study, due to the nature 
of the intervention (exercise) and outcome (patient questionnaire). Therefore, a 
high risk of performance bias was not taken into account when summing up the 
domains into the overall risk of bias. Three studies had a low risk of bias accord-
ing to the Cochrane collaboration’s tool, two studies had an unclear risk of bias 
(Table 3). The percentage risk of bias per item for all included studies is shown 
in Figure 2. 
Figure 2. Percentage risk of bias per item of all included studies
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Meta-analysis
The short-term effect of exercise on fatigue was calculated using the SMD of 
the intervention and control group at baseline compared to 4 weeks (Van den 
Ende 2000), 8 weeks (Reid 2011) or 12 weeks (Stavropoulos 2012 and Neuberg-
er 2007). The long-term effect was calculated using the SMD in fatigue score at 
baseline compared to 24 weeks (24-week data available for all studies). De Jong 
et al. (2003) did not collect short-term fatigue data and hence their data were 
only included in the analysis of effects of 24-weeks of exercise.
The pooled analysis of the effect of the results at ≤12 weeks of exercise on 
fatigue revealed a larger reduction of fatigue in the intervention group com-
pared to the control group, which was significant (SMD= -0.31, 95% CI= -0.55;-
0.06, p=0.02, I2=0%, (Table 4a)). 
The pooled analysis of the effect of 24 weeks of exercise on fatigue also 
showed a larger reduction of fatigue in the intervention group compared to the 
control group, however this was not significant (SMD= -0.15, 95% CI=-0.33;0.02, 
p=0.09, I2=2%,(Table 4b)).
Heterogeneity according to the I2 was low for both the short term and long term 
results.
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Table 4. Forest plot of standardized mean difference, with 95% confidence interval (95% CI) for 
fatigue score.*
* 4a. The difference in fatigue score between baseline and 8 or 12 weeks (short-term). 4b. The diffe-
rence in fatigue score between baseline and 24 weeks (long-term).  IV=inverse variance.
Sensitivity analyses
When comparing the studies with a low risk of bias (van den Ende 2000, Reid 
2011) with the other studies (Neuberger 2007, Stavropoulos 2012), the pooled 
analysis of the effect of short-term exercise on fatigue showed no effect in the 
low risk of bias group (SMD=-0.15, 95% CI= -0.57;0.27, p=0.50) but there was a 
larger and statistically significant effect of exercise on fatigue in the studies with 
an unclear risk of bias (Neuberger 2007, Stavropoulos 2012) (SMD=-0.39, 95% 
CI=-0.70;-0.09, p=0.01).
The pooled analysis comparing the study with fatigue as a reported primary
outcome (Neuberger 2007) versus all studies which did not report fatigue out-
comes in their published article, showed a larger reduction of fatigue in the study 
of Neuberger (SMD=-0.35, 95% CI=-0.68;-0.02, p=0.04). However, there was no 
effect of exercise training on fatigue in the pooled other studies (SMD=-0.25, 
95% CI=-0.62;0.11, p=0.17). 
The only study in which an exercise program longer than 24 weeks was in-
vestigated is the study of De Jong 2003, which was a two year supervised 
high-intensity group exercise program. The effect of the intervention group 
compared to the control group at 2 years was not significant (p=0.53); the in-
tervention group had a somewhat higher level of fatigue on the SF-36 vi-
tality scale at two years of exercising (+0.77 (15.5)) compared to baseline.
The pooled analysis comparing the studies with a short supervised part of the 
exercise program (≤12 weeks) (Reid 2011, Neuberger 2007, van den Ende 2000) 
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versus the studies with a longer supervised exercise program (24 weeks) (De 
Jong 2003, Stavropoulos 2012) showed a somewhat larger reduction in fatigue 
(not significant) in the studies with a longer supervised program (SMD=-0.30, 
95% CI=-0.95;0.36, p=0.37) than in studies with a shorter supervised program 
(SMD= -0.21, 95% CI=-0.48;0.06, p=0.13). 
 
Meta-regression
In most studies the average baseline fatigue score was similar and ranged be-
tween 45% and 55% of the maximum score possible; in one study the level of 
fatigue at baseline was below 20%. There was no significant relation (Figure 3) 
between the level of baseline fatigue score and the effect of the intervention on 
fatigue (β= -0.012 p=0.396, R2=0.25).
The study with the lowest baseline fatigue score is the only study in which
the benefit in the control group was larger than the benefit of the intervention 
group (a ‘reversed’ effect). If this study is omitted in the meta-regression, the 
level of baseline fatigue also does not have a significant effect on the interven-
tion effect (p=0.612).
The meta-regression of the relation between the effect on fatigue with the 
effect on disability/functioning showed that larger effects on disability were as-
sociated with larger effects on fatigue (β= 1.04 p=0.027, R2=0.947).
Figure 3. Meta-regression of baseline fatigue score and the effect of the intervention
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Discussion
This meta-analysis identified 5 RCT’s in which the effect of a supervised land-
based aerobic exercise program on fatigue in patients with RA was studied. Ac-
cordingly, this analysis showed by pooling the SMD of included studies that aero-
bic exercise training may be beneficial to treat fatigue in RA. The effect of aerobic 
exercise on fatigue was highest and statistically significant at 12 weeks, while this 
effect diminished over time with no significant effect found at 24 weeks. 
The 5 included trials were reasonably well performed and accordingly the 
overall risk of bias was judged as low. The main source of bias, common to all 
studies, was that the intervention could not be blinded for the patients while 
fatigue is being measured by patient questionnaire. This cannot be avoided, due 
to the nature of intervention and outcome. In the individual studies the effects 
of exercise on fatigue were not statistically significant, with one exception, show-
ing the advantage of meta-analysis if studies are small. However, the effect sizes 
in the individual studies also were relatively small, usually with a SMD of < -0.5. 
So far it can be concluded that in these RCTs, the effect of aerobic exercise for 
fatigue in RA was small at 12 and 24 weeks, with a low risk of bias.
Unfortunately, in the several RCTs different fatigue outcome measures were 
used. Three of the five included studies used the MAF as fatigue questionnaire 
(14, 27, 30) and two studies used a different fatigue outcome (28, 29). This ne-
cessitated the use of the dimensionless SMD to enable comparison between 
studies. However, the use of different outcome measures did not cause a lot of 
heterogeneity. Alas, of the 22 trials included in only 5 were fatigue outcomes 
assessed (14, 27-30) and in only one study fatigue was reported as the primary 
outcome measure. Notably, none of the trials selected patients with RA for hav-
ing fatigue. This may have contributed to the relatively small effect sizes that 
were found; the effects of an intervention to reduce fatigue may be larger if 
patients are selected on fatigue levels as indication. While in meta-regression 
it was shown that in most studies fatigue was present at baseline, there was no 
indication that the effect depended on baseline level, presumably because the 
baseline level of fatigue was quite similar for most studies. Also, it could be that 
the different lengths of the exercise program and the degree of adherence con-
tributed to the small effect size. It is conceivable that a number of participants 
may not have continued to exercise after the supervised training program was 
finished. Generally, supervised programs are more effective for inducing a sig-
nificant improvement in aerobic capacity than home aerobic exercise (23, 24). 
However, a recently performed RCT showed a significant effect of a home-based 
exercise program on fatigue (31). Three of the 5 included studies performed a su-
pervised exercise program less than 24 weeks. In our sensitivity analysis a larger 
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reduction in fatigue in the studies with a longer supervised exercise program was 
found compared to studies with a shorter supervised part, however not signifi-
cant. Evidence from meta-analyses and RCT’s showed that for CFS, CBT (10, 11) 
and exercise (9) are effective treatments. Therefore, there is reason to consider 
CBT and exercise as treatment modalities for fatigue in RA too. However, the 
factors contributing to fatigue are different in RA as compared to the CFS, with 
presence of chronic pain in RA as a predominant difference (18, 32). Thus, results 
in CFS cannot automatically be translated to RA. Regarding CBT to treat fatigue in 
patients with RA, several RCT’s have shown that it is effective, although effect siz-
es are small (11-13). Regarding exercise, there is some evidence to suggest that 
several exercise forms provide benefit to treat fatigue in RA, from two meta-anal-
ysis (15, 16). However, only one study on aerobic exercise was included in these 
meta-analyses. Although the evidence is not abundant and effects appear to be 
small, CBT and exercise appear to be promising interventions for the treatment 
of chronic severe fatigue in RA. This has also been suggested in patients with 
primary Sjögrens’ disease: fatigue might be reduced by targeting both physical 
activity and physical activity cognitions (33). 
The current meta-analysis concentrates on land-based aerobic exercise and 
included all currently available evidence including previously unpublished data 
in RA. Land-based exercise was chosen because this form of exercise is common, 
easy to implement in different forms (cycling, walking, ‘aerobics’) and the inten-
sity can be well regulated. Other forms of exercise such as strengthening exer-
cises or a “water based” or dance-based intervention program also could have 
positive effects on fatigue in RA (15). If the most beneficial intensity of aerobic 
exercise to treat RA fatigue would be known, clinicians could provide this guid-
ance to patients. If exercise has proven to be effective in a trial setting, physical 
exercise can be implemented by a guideline for the inter-disciplinary treatment 
of fatigue in RA, and implementation through patient organizations. For accept-
ability and adherence it would be advantageous if patients could choose their 
favorite mode of exercise. Many patients do not want to take part in intensive 
exercise for a prolonged period of time, therefore a good solution could be to 
bring the patients to a certain level of aerobic conditioning by a short intensive 
phase of the exercise program, and use patient preferred modes of exercise for 
the maintenance phase. One efficient way to train aerobic capacity for instance 
is cycling, it can be implemented as ‘spinning’ groups with or without peer-pa-
tients in the residential area of the patient and it can also be performed alone 
and/or at home. However also other exercise modalities can be used, such as 
(Nordic) walking, exercise at home, but also exercise at a regular sports center, 
exercise supervised by a therapist, or on an individual basis with an individual 
exercise program.  
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In conclusion, the current meta-analysis provided evidence that there may be 
a positive effect of a supervised aerobic exercise program on fatigue in RA, but 
the effect was small and non-significant at the long term. However, patients in 
these studies were not selected for having fatigue and therefore the effect may 
have been underestimated. For future research, we recommend performing a 
randomized study on the effects of exercise in patients with RA with fatigue as 
main outcome, in patients selected on high fatigue levels. In future, patients 
should be supported to continue the exercise program beyond the supervised 
part of the program, aiming to establish a better effect on the longer term. This 
could be performed by an internet-based individualized training even in combi-
nation with group contact moments (34, 35). In addition the optimal dose and 
frequency of exercising to establish an effect on fatigue in patients with RA is yet 
unknown and should be studied. Further it would be an advantage if a common 
fatigue outcome measure, such as the MAF, would be used in future trials, to 
facilitate meta-analyses. Also, the BRAF (Bristol Rheumatoid Arthritis Fatigue) 
could be included as an RA specific fatigue questionnaire, probably as a primary 
outcome measure (36). 
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Discussion
Fatigue is an important disturbing symptom for patients with RA and its aetiolo-
gy still remains unclear. The evidence base for the treatment of fatigue in RA is 
limited. This thesis was performed with the aim to gain more insight into factors 
associated with fatigue in RA, and especially to get more insight in the associ-
ation between physical activity and fatigue. We hypothesized that RA patients 
with severe fatigue are trapped in a vicious circle: a decrease in physical activity 
is associated with a higher level of fatigue which may lead to more mood distur-
bance and less sense of control over fatigue, associated with a further decrease 
in physical activity, and so on. To get a better understanding of fatigue and to 
find keys to treat fatigue, it is necessary to clarify the relations between fatigue, 
physical activity and other factors. 
Based on the chapters described in this thesis the main findings are:
• A change of fatigue is positively associated with a change of pain over the 
same period of time. A synchronous association was found and not a successive 
relationship.  Therefore both pain and fatigue should be treated because it can-
not be expected that an improvement in one is followed by an improvement in 
the other. 
• In RA patients, 25% had a low physical activity level, and 75% had a rela-
tively high activity level, as assessed using actigraphy. Patients with RA who had 
a relatively high level of daily physical activity reported less severe fatigue than 
patients with lower daily physical activity. Importantly, the level of physical ac-
tivity was not associated with fatigue related factors: pain, disability, coping, or 
cognition. 
• Patients with RA reported a higher level of fatigue and less minutes of 
physical activity per week (subjectively measured) compared to the general pop-
ulation. In RA a lower level of self-reported physical activity was associated with 
older age and longer disease duration. About half of the RA patients reported to 
participate in sports like fitness, swimming, strength training and walking.
• Testing  a hypothesized model of fatigue in RA, fatigue appeared to be 
influenced directly by poor sleep quality and physical functioning, and indirectly 
by sense of control, mood disturbance and pain.  Changing these factors by  psy-
chological interventions and/or physical activity might help to improve fatigue in 
patients with RA.  
• Results of a meta-analysis showed that an aerobic exercise program 
could be effective in reducing fatigue among patients with RA, especially in the 
short term, although the effects were small.
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Now, the main findings of this thesis will be discussed and implications of the 
findings will be put forward. 
Factors associated with fatigue 
Formerly, it has been assumed that chronic inflammation and inflammation 
associated anemia, and thereby depressive disorder were the most important 
causal factors of fatigue in RA. As chronic inflammation is a catabolic process, 
it may be hypothesized that inflammation leads to fatigue. However, there are 
contradicting results between DAS28, ESR, other inflammatory markers and their 
association with fatigue (1-6). It has been shown in multiple cross-sectional stud-
ies that pain, rather than inflammation e.g. as measured using the acute phase 
reactants or the number of swollen joints, is associated with fatigue in RA (3-
5). Consequently, the relation between inflammation and fatigue appears to be 
mediated through pain (7). Therefore it may be hypothesized that a change in 
pain may precede a change in fatigue. However, according to the results of this 
thesis it seems that pain and fatigue have a synchronous association rather than 
a temporal association. This may suggest that both pain and fatigue are driven by 
common factors.     
Although anemia and depressive disorder do occur in RA, they do not occur
so frequently that this can explain the high prevalence of fatigue in RA (8, 9). 
However, it has been shown that self-reported depressive symptoms are associ-
ated with RA fatigue (3, 5, 10-13). Other psychological factors related to higher 
fatigue in RA are: lower self-efficacy with respect to fatigue (3, 10, 11),  a per-
ceived lack of social support (3, 11), lower mental health (6), low self-esteem, 
catastrophizing of fatigue, strong somatic fatigue attributions, less social func-
tioning and coping strategies like worrying and resting (10). Longitudinal studies 
assessing fatigue at baseline and after one year, showed that pain, daily func-
tioning, and psychological factors such as self-efficacy and coping strategies are 
related to fatigue severity in RA (14-16). Physical functioning also is an important 
variable associated with fatigue in RA: several studies showed that fatigue was 
closely related to activity limitation (4, 6, 10, 15, 17). 
In 2011, Hewlett developed a conceptual model for fatigue in RA which pro-
vides an overview of all variables associated with fatigue derived mainly from 
cross-sectional studies (7). This model suggests bi-directional inter-relationships 
between and within three major factors: RA disease processes, cognitive/be-
havioural factors and personal/social factors (Figure 1). Combinations of these 
factors are likely to vary within and between patients, and subject to chang-
es over time. In addition, a  recently performed systematic review including all 
available evidence about factors associated with fatigue in RA until now, con-
cluded that three variables have a high probability to be involved in the complex 
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process of fatigue in RA: pain, disability/physical functioning and depression/
depressive mood (18), while more evidence was found for fatigue being related 
to pain and physical function than to depression. 
 
Figure 1. Conceptual model of RA fatigue of Hewlett et al. 2011. 
Accordingly, these factors seem to be the most important factors contributing to 
the presence of fatigue. However,  it is unknown if these factors are either cause 
or consequence of fatigue in RA. A causal relationship between these variables 
and fatigue in RA is difficult to establish, and needs testing in longitudinal obser-
vational studies or RCT’s with interventions for these factors. 
A first step towards how these factors together may contribute to fatigue in 
RA is by testing a multidimensional model using structural equation modeling 
(SEM). There was one previous study in which a multidimensional model for fa-
tigue in RA was tested, and a direct relationship between poor sleep quality, 
mood disturbance, disease activity and fatigue was found (19). Thereby, disease 
activity was indirectly associated with fatigue via mood disturbance and poor 
sleep quality. In CFS, also a model for fatigue was developed. CFS is a chronic 
disorder, different to RA, however in this model cognitive/behavioral factors and 
physical activity are, like in RA, also associated with fatigue. Therefore, in this 
thesis, a hypothesized model for fatigue was tested  based on the previously 
developed model for fatigue in RA (19)  and on the model for CFS (20). The 
results of the model developed in this thesis showed that RA fatigue is directly 
influenced by poor sleep quality and physical functioning, and indirectly by sense 
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of control, mood, and pain. Besides pain, physical functioning and mood (de-
pressive symptoms) as found in the systematic review of 2013 (18), poor sleep 
quality seems an important factor contributing to fatigue in RA. Indeed, a re-
cent cross-sectional study about predictors for fatigue in RA showed that besides 
pain, also depression, physical inactivity and sleep disturbances are associated 
with a higher fatigue level in RA (21). These combined findings corroborate the 
viewpoint that these factors are important causal factors of RA fatigue. There-
fore, it could be of interest to see whether these four factors are also associated 
with fatigue in other inflammatory diseases such as ankylosing spondylitis or 
Sjögren’s disease. If these factors  are generalizable to all chronic inflammatory 
disorders at least to some extent, this would facilitate knowledge transfer and 
evidence based treatments. Interestingly, previous models for fatigue in other, 
non-arthritic, chronic disorders showed that there may be some common factors 
indeed: psychological factors, pain and sleep disturbances (22-24). In patients 
with neuromuscular disorders, a direct relationship between sleep disturbances, 
self-reported physical activity and fatigue was found (22). Cancer-related fatigue 
in breast cancer patients  was directly associated with depression and anxiety, 
pain and altered vigilance (23).  In multiple sclerosis, higher pain levels were 
associated with higher levels of fatigue, anxiety, and sleep disturbance, which in 
turn were associated with higher levels of depression (24). 
In conclusion, in RA as well as some other chronic disorders, the most impor-
tant factors associated with fatigue are sleep quality, mood/depression, pain, 
and recently also physical functioning was mentioned as a contributing factor 
(7, 18, 19, 21-24). Physical functioning is a broad concept that reflects patient’s 
impairments, limitations related to movement, and ability to perform daily ac-
tivities. Physical functioning may be related to, but does not cover, the amount 
of daily activity a patient performs. Physical activity is defined as any bodily 
movement resulting in energy expenditure (25), including exercise  as well as 
non-exercise activities. The three most essential elements for optimal physical 
functioning with respect to the musculoskeletal system are range of motion 
(flexibility), strength and aerobic capacity (endurance) (26).  During the past de-
cades, advances in research have shed light on the role of exercise as a therapy 
for rheumatic diseases. The most important  advance is the discovery that skel-
etal muscle communicates with other organs by secreting proteins called myok-
ines. Some myokines are thought to induce anti-inflammatory responses with 
each bout of exercise and mediate long-term exercise-induced improvements in 
cardiovascular risk factors, having an indirect anti-inflammatory effect (25). One 
of the most prominent effects of exercise is the improvement in physical capacity 
which is particularly beneficial for patients with RA. The decrease in visceral fat 
as a consequence of exercise has also indirect anti-inflammatory effects (25). In 
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RA it is found that the positive benefits of physical activity are a reduction of car-
diovascular risk, a production of anti-inflammatory cytokines (25), an improved 
aerobic capacity and muscle strength, resulting in enhanced abilities in activities 
of daily living and health-related quality of life (27, 28). Physical activity could 
therefore increase RA patients’ physical functioning, and probably also reduce 
fatigue.
Level of physical activity 
Patients with RA are less physically active and reported more fatigue than healthy 
controls. But the question remains whether the level of physical activity and the 
level of fatigue are indeed associated in RA.  If they are associated, increasing the 
level of physical activity could be effective  to reduce fatigue in RA. 
In patients with other chronic conditions such as CFS, Sjögren’s syndrome, 
cancer and  Parkinson’s disease, a higher level of fatigue is associated with a low-
er level of physical activity (26-30). The results of this thesis showed that also in 
RA patients, higher fatigue levels are associated with lower levels of objectively 
assessed physical activity. The relation between fatigue and daily physical activ-
ity level in RA could not be explained by differences in pain, disability, coping, 
or cognition, or by other factors that can cause fatigue. Actigraphy, using an 
accelerometer, is a reliable and valid instrument for continuously and objectively 
measuring physical activity (31-33) and has already been used to quantify phys-
ical activity level in CFS (33), cancer survivors (34, 35), COPD (36), neuromus-
cular diseases (22)  and in other rheumatic diseases such as osteoarthritis (37). 
An easier way to assess physical activity is  by self-report, using questionnaires. 
However, for many persons  it is difficult  to recall their activity levels accurately, 
especially for light to moderate activities, and therefore the results of question-
naires may have been biased by cognitions concerning illness and disability (38). 
The advantage of accelerometers over self-report measures, is being able to ob-
jectively track intensity, duration and frequency of an activity even the light to 
moderate activities(39). Physical activity level measured in this thesis contains all 
kind of physical activities during a day, such as commuting, activities at work or 
school, household activities and leisure time activities including sport activities. 
By indirect comparison, it appeared that the level of physical activity in RA pa-
tients is somewhat higher than in CFS patients (33) and lower than in disease-free 
breast cancer survivors (40). A comparison of physical activity level between RA 
patients and healthy controls measured by actigraphy is not performed yet. A 
disadvantage of actigraphy is that it is a rather costly and time-consuming meth-
od.  Therefore, to compare the level of self reported physical activity in a large 
group of RA patients with the general population, the SQUASH questionnaire was 
used. Accordingly to this subjective measurement, RA patients reported lower 
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physical activity per week than the general population. Patients with RA are less 
active and have higher levels of fatigue than healthy controls, and this higher 
level of fatigue is related to a lower level of physical activity in RA. Therefore, it 
seems that RA patients should be encouraged to increase their physical activity 
level in order to decrease the level of fatigue. 
Treatment of fatigue
Based on the results of the multidimensional model for RA fatigue,  a suggestion 
can be made that treatments aimed at the following five factors: pain, mood dis-
turbance, sense of control, sleep and physical functioning, could help to reduce 
fatigue in RA. In RA, pain is largely caused by the inflammatory process  and is 
treated with anti-rheumatic medication (41). However, anti-inflammatory  treat-
ment alone is insufficient to treat fatigue as fatigue frequently occurs in patients 
with low or moderate disease activity (16). In addition a direct effect of anti-TNF 
on fatigue in RA has been suggested, however it appears that anti-TNF has no 
complementary effect on chronic fatigue (42). Finally, this thesis showed that 
changes in pain and fatigue occur synchronous  in RA, suggesting that  one does 
not precede the other. This may mean that the effect of pain ‘causing’ fatigue is 
limited. 
Psychological interventions, notably CBT, can be used for improving sense of 
control over symptoms, mood and sleep quality. However, CBT can also have 
positive effects on physical functioning and can also be used to increase the 
level of  physical activity, as is done in CBT for CFS for example (43, 44).  In RA, 
studies of Hewlett and Evers indicated that CBT, alone with a psychologist or 
group-based,  improves fatigue, coping and well-being in RA and has also positive 
effects on disability (45, 46). However, only moderate effects of CBT on fatigue in 
RA were found (45-47). A disadvantage of CBT is that trained therapists (in CBT 
for fatigue) are necessary and it is rather expensive. Therefore CBT interventions 
for fatigue are rarely offered routinely by clinical psychologists. More often RA 
patients with severe psychological problems are offered CBT for their problems, 
not for fatigue. 
Little has been reported on the efficacy of CBT in reducing sleep disturbances 
in patients with RA (48), although occasionally improvements in subjective sleep 
quality after CBT has been found (49). Interestingly, a recent not yet finished trial 
is investigating the effect of intermittent aerobic exercise on the improvement of 
sleep in patients with RA (50). The hypothesis of the  effect of aerobic exercise on 
the improvement of sleep is based on the results of cross-sectional studies that 
physical inactivity increases the likelihood of reporting poor sleep (51) and it has 
been reported that maximal aerobic capacity is lower in patients with insomnia 
compared to those without it (52). In addition,  physical exercise interventions 
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have been shown to be a feasible and moderately effective non-pharmacological 
treatment for improving sleep in healthy and in clinical populations (53, 54). Be-
sides a positive effect on sleep, increasing physical activity level could increase 
RA patients’ physical functioning. A systematic review showed a significant im-
provement in physical functioning by graded exercise therapy (GET) in CFS pa-
tients: exercise in which the incremental increase in exercise was mutually set 
(44).  While acknowledging that CFS and RA are different disorders, increasing 
physical activity could also be a promising treatment for RA fatigue. 
Increasing physical activity level as a treatment for fatigue
Physical activity in the broadest context includes all body movements resulting in 
energy expenditure, including sports as well as non-sports activities such as oc-
cupational and household activities (55). Sports or exercise is a subset of physical 
activity, which can be defined as planned, structured and repetitive activity with 
the objective of improving or maintaining physical fitness (55). 
Consequently, increasing physical activity level can be performed with or with-
out inclusion of intensive exercising. However, physical activity below a minimum 
intensity will not challenge the body sufficiently to result in increased aerobic 
capacity and improvements in other physiological parameters (56). To increase 
physical functioning in RA patients by increasing strength and aerobic capacity, 
dynamic exercise seems effective. A cardiorespiratory (dynamic) aerobic exer-
cise should be performed at 50%-80% of the maximal heart rate (220-age) to 
increase aerobic capacity (57). 
Systematic reviews concluded that dynamic exercise in patients with RA is ef-
fective with respect to the improvement of aerobic capacity and muscle strength, 
without detrimental effects on disease activity, pain or radiological joint damage 
(58, 59)  and more benefits were seen in these parameters with high intensity ex-
ercise, compared to low intensity exercise (60). Regarding fatigue, there is some 
evidence to suggest that several exercises provide benefit in RA (61, 62). These 
meta-analyses included different forms of physical activity (pool-based therapy, 
yoga, dynamic strength training, stationary cycling, low impact aerobics and Tai 
Chi) with different intensities.  However, only one single RCT in patients with RA 
has been performed on aerobic exercise, with an intensity between 50%-80% 
of the maximal heart rate, with fatigue as dedicated primary outcome measure 
(63). This RCT found that fatigue decreased significantly for the exercise group 
compared to the control group (63). However, there are some other trials per-
forming an aerobic exercise program in RA  and did measure fatigue as outcome 
but did not publish the results of fatigue. Therefore, in this thesis a meta-analysis 
was performed to summarize the limited evidence of the effect of an aerobic 
exercise program on fatigue and to get a better estimate of the mean effect. 
Discussion 127
1
2
3
4
5
6
7
Published and notably also unpublished fatigue data were collected from trials. 
The results of this meta-analysis showed that a supervised aerobic land-based 
exercise program may be beneficial to treat fatigue in RA at 12 or 24 weeks, al-
though the effect for both time points was small and only significant at 12 weeks. 
It seems that maintenance is a concern; patients stopped exercising or exercised 
less intensive after the supervised part of the training program. To maintain ex-
ercising patients should be motivated and coached. 
Exercise seems a promising intervention to treat fatigue in RA, although there 
is no definitive evidence for its efficacy. In other chronic diseases such as breast 
cancer survivors, a supervised aerobic exercise program is effective for fatigue 
(64). However, in the context of CBT for CFS and post-cancer fatigue patients, 
it appeared that an increase in physical activity level was not the mediator of a 
reduction in fatigue level (34, 35, 65). It turned out that cognitions mediated the 
decrease in fatigue and not the increase in physical activity.  However this does 
not mean that increasing physical activity level could not be effective in reducing 
fatigue in RA, apart from the question of mediative factors. Future research is 
necessary to investigate the effects of increasing physical activity by an exercise 
program on fatigue in RA, and next also the mediators of these effects. 
Effect of exercise on fatigue in patients with rheumatoid arthritis: A pilot study
A pilot study was performed by our group with the aim to investigate the feasi-
bility of 12-weeks of supervised aerobic exercise, versus no exercise, on fatigue 
levels in 24 patients with RA having severe fatigue for at least 6 months. For this 
pilot study we could make use of a training facility at noon, 2-3 times a week. 
However, the combination of training frequency and time point appeared to be 
a hindrance for many potential participants and  it was not possible to include 
enough patients in 6 months. Finally, five patients were included in the interven-
tion group and two patients in the control group. The intervention consisted of a 
12-week supervised aerobic exercise program on a bicycle ergometer. The first 6 
weeks RA patients performed 2 times a supervised personalized interval training 
of approximately 50 minutes and 3 times per week in the second period of 6 
weeks. The control group did not participate in the supervised aerobic exercise 
program. Measurements of fatigue, aerobic performance (VO2 max), disease ac-
tivity (DAS28), pain (VAS), disability (HAQ), self-efficacy concerning fatigue, cop-
ing, grip strength, cardiovascular risk factors, kinesiophobia, daily activities and 
sport participation were measured at four time points, both in the intervention 
group and in the control group.  The pilot study was not aimed at finding a treat-
ment effect, but to gain insight in the feasibility and limitations of an exercise 
program for RA patients. The participating RA patients were very enthusiastic 
and content with the exercise program, felt less fatigued and felt encouraged 
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to continue exercising. The patients experienced that that there was need for a 
more varied program, than cycling alone. A joined warming up with various types 
of exercises would be a nice addition to the program. RA patients mentioned 
they would like to train their whole body instead of only their legs, with additive 
types of sport; this type of combined exercise may feel more balanced. 
Therefore in future studies,  it would be beneficial  if patients would choose 
their preferred exercise mode themselves, self-determine when to exercise, self-
pace their exercise and have monitoring and feedback. A personalized graded 
activity program combines the operant-conditioning behavioural approach with 
increasing the activity level, as applied in osteoarthritis and the chronic fatigue 
syndrome (66-68) and fits well to these needs. The program is directed at enhanc-
ing physical activity adherence and gradually increasing the amount of physical 
activity in a time-contingent way so that activities are gradually increased by pre-
set quotas regardless of impairments (69). To facilitate initiation and adherence 
patient perceptions about fatigue and physical activity will be explored and  dis-
cussed with the patient by means of motivational interviewing techniques.  For 
the maintenance phase of physical activity, RA patients should self-pace their ex-
ercise and have monitoring and feedback besides being coached by a supportive 
professional. Monitoring and feedback could be performed  by an internet-based 
individualized training even in combination with group contact moments togeth-
er with other RA patients (70, 71). Other forms of internet-based supervised 
monitoring and motivation of physical activity level are mobile applications for 
advice regarding physical activity exercises developed in patient groups such as 
Bechterew disease (72) and in Parkinson’s disease (73).  
Clinical implications and future research
There still is no evidence based strategy available which is sufficiently effective 
for treatment of fatigue in RA patients. In the clinic, for RA patients pain and 
fatigue are the most important symptoms of the disease. While disease activity 
can be well treated nowadays, there is still not enough treatment possibilities to 
treat fatigue. The studies in this thesis provide knowledge about which factors 
the treatment of fatigue in RA patients should be focused on: sleep quality, phys-
ical functioning, pain, sense of control and mood disturbance. 
This has several clinical implications for the treatment of RA fatigue:
• In RA,  pain and fatigue should both be treated. 
• Sleep quality is another issue that should be paid attention to in the clin-
ic.  
• A psychological intervention, preferably CBT, could be an effective treat-
ment for the factors mood disturbance, sense of control, sleep functioning and 
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eventually physical functioning.
• Increasing physical activity level could be a promising treatment for RA 
fatigue, by breaking a vicious circle: a higher level of physical activity is associ-
ated with a lower level of fatigue which may lead to less mood disturbance and 
more sense of control over fatigue, associated with more physical activity in RA.
• Increasing physical activity level can be performed with an exercise pro-
gram and/or with a graded activity program.  
However, the optimal and most effective way to increase physical activity level 
in RA is not known yet and we don’t know the effectiveness of such an interven-
tion on fatigue. One of the big issues is that patients have difficulties to adhere 
and comply to prolonged exercise and to maintain activity level  in daily life. 
Patient perceived barriers and limitations of exercise that should be dealt with 
in devising and performing interventions. Accordingly future research should be 
performed:
• To investigate if a personalized graded activity program is effective to 
increase the level of physical activity in RA patients.
• It should be investigated how to maintain physical  activity e.g. by mon-
itoring and feedback and the best way to incorporate physical activity in RA pa-
tients’ daily life. 
• To provide evidence whether an aerobic exercise program is effective for 
fatigue in RA patients, especially in severe fatigue. 
• The most beneficial intensity of aerobic exercise, irrespective of the 
mode of exercise (e.g. cycling, swimming, walking), to treat RA fatigue should be 
investigated.
• To investigate the mediators of the effect of increasing physical activity 
on fatigue in RA.
If future research confirms that exercise indeed is effective and if the most ben-
eficial intensity of aerobic exercise to treat fatigue would be known, physical 
exercise can be implemented and finally clinicians could provide this guidance to 
patients.  However, apart from a possible effective treatment for fatigue in RA, 
physical activity has several other beneficial effects on health for people with RA, 
such as reduction of cardiovascular risk, increasing aerobic capacity, increasing 
muscle strength, and reducing  pain and disability.
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In RA, fatigue is a frequently occurring and patient-relevant complaint which by 
patients is experienced as debilitating and restricting daily functioning. At least 
40% of the RA patients is severely fatigued and until now no established treat-
ment for fatigue in RA is available. This thesis was performed with the aim to gain 
more insight into factors associated with fatigue in RA, and especially the asso-
ciation between physical activity and fatigue. We hypothesized that RA patients 
with severe fatigue may come into a vicious circle: a decrease in physical activity 
is associated with a higher level of fatigue, which leads to more mood distur-
bance and less sense of control over fatigue, associated with a further decrease 
in physical activity, etcetera. Clarifying the relationships between fatigue, phys-
ical activity and other factors may lead to better understanding of fatigue and 
improvement of treatment of fatigue. These ideas are delineated in chapter 1.
Pain and fatigue are mentioned by RA patients as the two most disturbing 
symptoms of the disease and usually they do co-occur. From a cause-effect point 
of view, it is not clear whether a change in pain may precede a change in fatigue, 
or the other way round? In chapter 2 the course of fatigue and the course of pain 
in RA patients over a period of one year was investigated while pain and fatigue 
were measured every month.  It was shown that, on average, the course of pain 
and fatigue were stable over time, but within patients there was considerable 
monthly fluctuation in pain and fatigue scores. However, a change in fatigue is 
positively associated with a change in pain at the same time. Thus, a synchronous 
relation between fatigue and pain was found rather than showing a temporal re-
lationship with a time lag. Probably both pain and fatigue are driven by common 
factors, that may probably be psychologically of nature. The clinical implication 
is that both manifestations should be treated because it cannot be expected that 
an improvement in one is followed by an improvement in the other.
In patients with chronic disorders other than RA, such as the Chronic Fatigue 
Syndrome (CFS), fatigue seems to be associated with a low level of physical activ-
ity. However, whether such an association also exists in RA has not been reported 
so far. In chapter 3 it was investigated whether objectively measured activity lev-
els and activity patterns were associated with fatigue levels in patients with RA, 
and  whether pain, disability, coping, and/or cognition are associated with—or 
influence—the level of activity among patients with RA. Physical activity in RA 
has not been measured objectively before, but we measured the level of physical 
activity using an actometer during 14 consecutive days. This study showed that 
the average activity level of patients with RA appears to be lower than in healthy 
controls and higher than in patients with CFS. Moreover, patients with RA who 
had a high level of daily physical activity were less fatigued than patients with 
low daily physical activity; and, the level of activity was not associated with pain, 
disability, coping, or cognition.
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While fatigue is prevalent in RA, it appears not to be uncommon in the gen-
eral population. To investigate whether fatigue indeed is more severe in RA than 
in the general population, in chapter 4 the level of fatigue between RA patients 
and the general Dutch population was compared. In addition, the level of physi-
cal activity (subjectively measured) was compared between RA patients and the 
general population and it was described how many RA patients were engaged 
in sports and in which sport activities. Interestingly, both half of the RA patients 
(52%) and half of the people from the general population (54%) were meeting 
the physical activity recommendation. At the same time it showed that patients 
with RA do have less minutes of physical activity per week and higher levels of 
fatigue, compared to the general population. At least once a week, 59% of the 
RA patients participated in sports, with fitness, swimming, strength training and 
walking as the most popular sports. Most frequently mentioned limitations to 
begin with a new sport are physical impairment, unawareness of the options and 
fear of injuries.
Besides pain and less physical functioning, previous studies reported that 
depressive symptoms, sleep disturbances, and psychological factors such as 
self-efficacy and coping strategies are related to fatigue severity in RA. How 
these factors together may contribute to fatigue in RA is studied in a multidi-
mensional model for fatigue developed and tested in chapter 5. According to the 
multidimensional path analysis model developed in this study,  RA fatigue was 
influenced directly by poor sleep quality and physical functioning, and indirectly 
by sense of control, mood and pain. This indicates that poor sleep quality and 
a lower physical functioning are directly associated with a higher fatigue level. 
Indirectly, more pain was associated with less physical functioning; more mood 
disturbance was associated with poor sleep quality. Less sense of control was as-
sociated with more mood disturbance, more pain and less physical functioning. 
The five factors: pain, mood disturbance, sense of control, sleep disturbances 
and less physical functioning, found in this model can be regarded as important 
associated factors of fatigue in RA with possible implications for fatigue treat-
ment. If these factors could effectively be treated, this may lead to improvement 
in patients’ fatigue.    
There is still limited evidence regarding effective interventions to treat RA fa-
tigue. In CFS there is most evidence for beneficial effects of cognitive behavioural 
therapy and for exercise. It therefore is useful to regard these as candidate in-
terventions in RA, while recognizing different mechanisms may be involved in 
fatigue in RA and in CFS. In RA, only a moderate effect of cognitive behavioral 
therapy for fatigue is found. As an increased level of physical activity is associ-
ated with a lower level of fatigue in RA, increasing the level of physical activity 
could be a reasonable treatment indeed. Presumably, training the aerobic ca-
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pacity of an individual, by exercising between 50-90% of maximal heart rate, 
has positive effects on overall condition/physical fitness and could therefore also 
have positive effects on fatigue in patients with RA. However, there is a lack of 
evidence regarding training aerobic capacity and the effect on RA fatigue. A me-
ta-analysis of aerobic exercise programs on fatigue was performed in chapter 6, 
including published as well as unpublished fatigue outcomes. The results of this 
meta-analysis showed that a supervised aerobic exercise training may be ben-
eficial to treat fatigue in RA, especially on the short-term, but the effects sizes 
were small.
In chapter 7, the main findings were discussed and the clinical implications 
and recommendations for future research were given. The results of this thesis 
showed that patients with RA are less active and have higher levels of fatigue 
than healthy controls, and this higher level of fatigue is related to a lower level 
of physical activity in RA. Raising daily physical activity level, with or without in-
tensive exercising, could be a promising treatment for fatigue in RA by breaking 
a vicious circle. Future research should be performed to confirm this. If exercise 
indeed is effective, this would constitute a relatively cheap intervention which 
can be implemented in a guideline for the inter-disciplinary treatment of fatigue 
in RA and implemented through patient organizations. 
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Vermoeidheid wordt door veel patiënten met Reumatoïde Artritis (RA) als klacht 
aangegeven. Tenminste 40% van de patiënten met RA heeft last van ernstige ver-
moeidheid, met grote gevolgen voor de kwaliteit van leven van deze patiënten. 
Er is tot op heden nog geen algemeen geaccepteerde effectieve behandeling 
gevonden voor vermoeidheid bij RA. 
In dit proefschrift getiteld: Physical activity and fatigue in rheumatoid arthri-
tis: a vicious circle? is onderzocht welke factoren een relatie hebben met ver-
moeidheid bij patiënten met RA. Speciaal wordt gekeken naar het verband tussen 
lichamelijke activiteit en vermoeidheid. Onze hypothese was dat patiënten met 
RA met vermoeidheid in een vicieuze cirkel raken: een verminderde lichamelijke 
activiteit leidt tot een toename in vermoeidheid, deze toename in vermoeidheid 
leidt tot het idee minder vat te hebben op deze vermoeidheid, wat weer leidt tot 
nog minder lichamelijke activiteit, enzovoort. Het doorbreken van deze vicieuze 
cirkel zou een verbetering kunnen geven van de vermoeidheid. Het doel van dit 
proefschrift was enerzijds om inzicht te krijgen in de relatie tussen lichamelijke 
activiteit en vermoeidheid en anderzijds het in kaart brengen van andere belan-
grijke factoren die een verband hebben met vermoeidheid bij patiënten met RA. 
Dit zou kunnen leiden tot een betere behandeling van vermoeidheid bij RA. 
In hoofdstuk 1 van dit proefschrift wordt een inleiding gegeven over ver-
moeidheid bij RA. Pijn en vermoeidheid zijn beide heel belangrijke klachten 
voor patiënten met RA en deze twee klachten komen vaak tegelijkertijd voor. 
Het is echter niet bekend of pijn veroorzaakt wordt door vermoeidheid of dat 
vermoeidheid juist veroorzaakt wordt door pijn; of is er eerder een gezamenlijke 
oorzaak? In hoofdstuk 2 is de relatie tussen vermoeidheid en pijn in een longi-
tudinale studie onderzocht. Een groep patiënten met RA heeft een jaar lang de 
mate van vermoeidheid en de mate van pijn bijgehouden. Op die manier konden 
we kijken of toename of afname in pijn gevolgd werd, of vooraf ging, aan veran-
deringen in vermoeidheid. De resultaten van deze studie laten zien dat gemid-
deld genomen, pijn en vermoeidheid helemaal niet veel veranderen. Maar bij 
individuele patiënten zijn er wel schommelingen in pijn en vermoeidheid. Het 
bleek dat een toename (of afname) van pijn samen ging met een gelijktijdige toe-
name (of afname) van vermoeidheid; het een ging dus niet aan het ander vooraf. 
Het lijkt er daarom op dat vermoeidheid en pijn bij RA aparte klachten zijn en 
daarom ook allebei behandeld moeten worden.
Onze hypothese was dat bij patiënten met RA met vermoeidheid een vermin-
derde lichamelijke activiteit leidt tot een toename in vermoeidheid. Deze toe-
name in vermoeidheid leidt tot het idee minder vat te hebben op deze vermoe-
idheid, wat weer leidt tot nog minder lichamelijke activiteit. In hoofdstuk 3 van 
dit proefschrift is daarom onderzocht of vermoeidheid en lichamelijke activiteit 
aan elkaar gerelateerd zijn. Het zou kunnen dat patiënten met RA die meer moe 
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zijn ook minder bewegen. Daarnaast werd gekeken of de hoeveelheid dagelijkse 
beweging samenhangt met pijn, verminderd lichamelijk functioneren, omgang 
met RA klachten (coping strategieën) en opvattingen over RA klachten (cogni-
ties). Daartoe is gedurende 14 achtereenvolgende dagen de dagelijkse activiteit 
bij patiënten met RA objectief gemeten met behulp van een apparaatje gedra-
gen om de enkel, een actometer. Volgens de resultaten was er een verband: 
meer dagelijkse lichamelijke beweging hing samen met minder vermoeidheid. 
De hoeveelheid dagelijkse beweging hing echter niet samen met pijn, lichamelijk 
functioneren, de manier van omgaan met de klachten en de manier van denken 
over de klachten. 
Om inzicht te krijgen hoeveel patiënten met RA nu eigenlijk bewegen en hoe 
moe ze zijn in vergelijking tot gezonde mensen, hebben we de hoeveelheid dage-
lijkse beweging en de mate van vermoeidheid bij patiënten met RA in hoofdstuk 
4 vergeleken met een grote groep mensen uit de algemene Nederlandse bev-
olking. Dagelijkse activiteit werd gemeten met behulp van een vragenlijst over 
bewegen. In deze vragenlijst werd bij patiënten met RA ook nagevraagd hoe vaak 
ze deelnemen aan sportactiviteiten en welke sport zij beoefenen en de eventu-
ele beperkingen om niet aan sport deel te nemen beschreven. De resultaten uit 
deze vragenlijst lieten zien dat patiënten met RA een gemiddeld hogere mate 
van vermoeidheid hebben en minder minuten per week besteden aan dagelijkse 
lichamelijke activiteiten in vergelijking met de algemene Nederlandse bevolk-
ing. Echter, er wordt geen verschil gevonden in het percentage patiënten met 
RA dat voldoet aan de norm van ≥5 keer per week een middelmatig intensieve 
inspanning van ≥ 30 minuten, vergeleken met het percentage uit de algemene 
Nederlandse bevolking wat voldoet aan deze norm, voor beide groepen was dit 
ongeveer 50%. Van de patiënten met RA neemt 59% ten minste 1 keer per week 
deel aan een sport en daarbij zijn de meest populaire sporten onder patiënten 
met RA fitness, zwemmen, krachttraining en wandelen. Daarnaast heeft 32% van 
de patiënten met RA zin om aan een nieuwe sport te beginnen. Patiënten met 
RA geven als redenen om niet te sporten aan dat het lichamelijk niet mogelijk is, 
dat zij niet op de hoogte zijn van het bestaan van sportmogelijkheden of dat zij 
bang zijn voor blessures. 
Naast lichamelijke activiteit spelen ook andere factoren een rol bij vermoeid-
heid bij RA. Resultaten uit verschillende studies laten zien dat de factoren pijn, 
verminderd lichamelijk functioneren, depressieve symptomen, slaapklachten, en 
psychologische factoren zoals een negatieve self-efficacy (het idee geen vat te 
hebben op de klachten) en de manier van omgaan (coping strategieën) een relat-
ie hebben met een hogere mate van vermoeidheid bij RA. Echter, deze mogelijke 
voorspellers voor vermoeidheid geven nog geen informatie over een oorzakelijk 
verband en het is nog niet bekend hoe deze factoren gezamenlijk bijdragen aan 
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vermoeidheid. In hoofdstuk 5 van dit proefschrift is daarom een multi-dimen-
sioneel model voor vermoeidheid getoetst om te onderzoeken hoe deze factoren 
samen bijdragen aan vermoeidheid. Door middel van een statistische techniek 
zijn directe en niet directe verbanden tussen de variabelen getoetst op basis van 
onze hypothese. Uit de resultaten van dit model blijken slechte slaapkwaliteit en 
verminderd lichamelijk functioneren direct gerelateerd te zijn aan meer vermoe-
idheid bij RA. Deze vijf factoren: pijn, angst en depressie, geringere self-efficacy, 
slechter slapen en slechter lichamelijk functioneren lijken het sterkst verbonden 
te zijn met vermoeidheid bij RA . Als deze factoren effectief behandeld worden, 
zal dit kunnen leiden tot een afname van vermoeidheid bij de patiënt met RA.  
Er is momenteel geen effectieve behandeling voor vermoeidheid bij RA. Er is 
wel wat bewijs dat cognitieve gedragstherapie, wat een effectieve behandeling 
is bij patiënten met het chronisch vermoeidheidssyndroom, ook zou kunnen hel-
pen bij verlichting van vermoeidheid bij patiënten met RA. Echter, de effecten 
van cognitieve gedragstherapie op vermoeidheid bij RA zijn beperkt. Eerder bes-
chreven we een relatie tussen meer dagelijkse lichamelijke activiteit en minder 
vermoeidheid bij patiënten met RA. Meer dagelijkse activiteit zou daarom een 
goede aanvullende en ondersteunende effectieve behandelingsmogelijkheid 
kunnen zijn voor vermoeidheid bij patiënten met RA. Deze behandeling zou de 
vicieuze cirkel kunnen doorbreken: meer lichamelijke activiteit zou bij patiënten 
met RA met vermoeidheid tot een vermindering in vermoeidheid kunnen leiden, 
deze vermindering in vermoeidheid leidt tot het idee meer vat te hebben op deze 
vermoeidheid, wat weer zou kunnen leiden tot nog meer lichamelijke activiteit. 
Naast meer dagelijkse activiteit in het algemeen, is het mogelijk dat sporten 
een nog groter effect kan hebben op vermoeidheid. Daarom hebben we in 
hoofdstuk 6 van dit proefschrift een meta-analyse uitgevoerd naar het effect van 
sporten op vermoeidheid. In deze meta-analyse werden alle gerandomiseerde 
gecontroleerde studies geïncludeerd die een inspanningsprogramma onder be-
geleiding van een deskundige bij patiënten met RA hebben uitgevoerd. Zowel 
studies die vermoeidheid als uitkomstmaat hebben gerapporteerd alsmede de 
studies die dat niet hebben gedaan zijn opgenomen in onze meta-analyse. De 
resultaten van deze meta-analyse laten zien dat een inspanningsprogramma 
gericht op verbetering van de fitheid ook positieve effecten kan hebben op ver-
moeidheid, maar de gevonden effecten zijn klein. 
In hoofdstuk 7 worden de belangrijkste bevindingen bediscussieerd. Klinische 
implicaties en aanbevelingen voor toekomstig onderzoek worden gegeven. De 
resultaten van dit proefschrift laten zien dat patiënten met RA minder lichamelijk 
actief en meer vermoeid zijn dan mensen zonder deze ziekte. Bij patiënten met 
RA hangt meer vermoeidheid samen met minder lichamelijke activiteit. Door 
middel van meer lichamelijke activiteit in het algemeen, en/of het volgen van 
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een inspanningsprogramma kan de vicieuze cirkel doorbroken worden. Hiermee 
kan het een veelbelovende behandeling zijn voor vermoeidheid bij RA.
Nieuw onderzoek zal moeten worden uitgevoerd, specifiek bij ernstige ver-
moeide  patiënten met RA, om dit bewijs te kunnen leveren en daarnaast moet 
onderzocht worden hoe deze behandeling het beste in het dagelijkse leven van 
de patiënt ingepast kan worden. Mocht een lichamelijk inspanningsprogramma 
voldoende effectief blijken om vermoeidheid te verminderen, dan zou dit deel 
kunnen uitmaken van een richtlijn voor de behandeling van vermoeidheid bij RA. 
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  Questionnaire
CAL  Causal Attribution List
CBT  Cognitive Behavioural Therapy
CFI  Comparative Fit Index
CFS  Chronic Fatigue Syndrome
CIS  Checklist Individual Strength
COPD  Chronic Obstructive Pulmonary Disease
CRP  C-Reactive Protein
DAS28  Disease Activity Score in 28 joints
DI  Disability Index
DMARD Disease Modifying Antirheumatic Drug
ESR  Erythrocyte Sedimentation Rate
FACIT-F  Functional Assessment Chronic Illness Therapy Fatigue
FCS  Fatigue Catastrophizing Scale
FM  Fibromyalgia
FSS  Fatigue Severity Scale
GET  Graded Exercise Therapy
GH  General Health
HAQ  Health Assessment Questionnaire
IQR  Interquartile Range
MAF  Multidimensional Assessment of Fatigue
MPCI-F  Modified Pain Coping Inventory for Fatigue 
MS  Multiple Sclerosis
MTX  Methotrexate
NBS  Nijmegen Biomedical Study
NRS  Numerical Rating Scale
OMERACT  Outcome Measures in Rheumatology Clinical Trials 
RA   Rheumatoid Arthritis
RCT  Randomized Controlled Trial
RMSEA  Root Mean Square Error of Approximation
RSO  Richtlijnen Sportdeelname Onderzoek 
SCL-90  Symptom Checklist-90
SD  Standard Deviation
SE  Standard Error
SEM  Structural Equation Modeling
SES  Self-Efficacy Scale
List of 151
1
SF-36  Short Form health survey 36-item
SFQ  Shortened Fatigue Questionnaire
SJC28  Swollen Joint Count in 28 joints
SMD  Standardized Mean Difference
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Graag wil ik iedereen bedanken die een bijdrage heeft geleverd aan de totstand-
koming van dit proefschrift: 
Allereerst Piet, als mijn promotor wil ik je heel erg bedanken voor de kans die 
je me hebt gegeven dat ik in september 2010 op de afdeling reumatische ziekten 
kon starten met een promotietraject. Ik mocht beginnen met onderzoek naar 
ernstige infecties bij biological gebruik en het vervolg van het coördineren van 
de DREAM time studie. Na een paar succesvolle publicaties mocht ik overstap-
pen naar het onderwerp vermoeidheid en beweging wat toch meer mijn ding 
werd. Ik vond het heel fijn dat je mij deze kans gaf en ik kwam altijd graag bij je 
langs voor advies of een gezellig praatje. Je was een hele fijne promotor, bedankt 
voor alles! Daarnaast wil ik je erg bedanken dat je me de kans hebt gegeven dat 
ik meteen na de afronding van dit proefschrift mijn loopbaan kon vervolgen als 
coördinator zorginnovatie op de afdeling reumatologie in het Bernhoven zieken-
huis te Uden. Een erg uitdagende en leuke baan waarvan ik hoop dat onze ideeën 
gerealiseerd kunnen gaan worden. 
Gijs, toen ik overstapte naar het onderwerp vermoeidheid ben ook jij mijn 
promotor geworden. Een paar maanden later ging jij genieten van je pensioen 
maar door jouw interesse ben je nog wel altijd betrokken geweest bij mijn onder-
zoek. We zagen elkaar daarom niet zo heel vaak, maar hadden altijd leuk contact. 
Ik wil je hartelijk bedanken voor al je hulp en kritische blik op dit proefschrift. 
Jaap, als co-promotor wil ik je heel erg bedanken voor al je hulp, advies, cor-
recties en statistische uitleg. Jij zorgde er meteen voor dat ik me op mijn gemak 
voelde in de onderzoeksgroep en ik kon altijd met al mijn vragen bij jou terecht. 
Eigenlijk had je op iedere vraag altijd wel een antwoord, ik heb zoveel van je ge-
leerd! Daarnaast was je ook wel in voor wat ontspanning naast het werk, samen 
een rondje mountainbiken tijdens de schrijfweek zal ik niet snel meer vergeten. 
Bedankt voor alles, zonder jou was dit proefschrift nooit tot stand gekomen!
Han, toen ik overstapte naar het onderwerp vermoeidheid ben jij mijn co-pro-
motor geworden. Vanaf toen was jij mijn grote voorbeeld in het vermoeidhe-
ids-onderzoek!  Ik kon altijd alles aan jou vragen en je stond altijd voor me klaar. 
We zaten vaak op dezelfde lijn en konden ook goed kletsen over andere dingen 
als we bij jaap voor de deur stonden te wachten. Ik hoop dat ik het goede vervolg 
heb gegeven op jouw proefschrift. Ik wil je bedanken voor al je hulp en de hele 
leuke tijd samen!
Graag wil ik Prof. dr. M.T.E. Hopman, Prof. dr. T.P.M. Vliet Vlieland en Prof. dr. 
R. Westhovens hartelijk bedanken voor hun bereidheid zitting te nemen in mijn 
manuscriptcommissie. 
Jos en Kavish, mijn roommates. Toen ik begon in 2010 kwam ik als meisje op 
jullie ‘mannenkamer’ terecht. Toch voelde me ik er al heel snel thuis tussen al 
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het gepraat over computerprogramma’s,  ibood, dexter, walking dead, home-
land, wie is de mol, expeditie robinson, en ik vergeet er vast nog een paar. We 
hebben een erg gezellige tijd gehad en ik kon ook altijd met mijn serieuze vragen 
bij jullie terecht. Helaas gingen jullie mij eerder verlaten en bleef ik alleen als 
meisje over op de ‘mannenkamer’. Maar vandaag staan jullie naast mij als para-
nimf, dank daarvoor! Hopelijk blijven we nog lang contact met elkaar houden en 
de etentjes houden we erin! 
Sofie, Marieke, Elke, Wieneke, Yvonne, enorm bedankt voor alle gezelligheid 
van de afgelopen jaren. Samen sinterklaas vieren, de aesculaaf en la cubanita 
zal ik gaan missen! Maar.. we hebben de watsapp nog, zo blijven we goed op de 
hoogte van elkaar. 
Graag wil ik ook alle stagiaires bedanken die mee hebben gewerkt aan mijn 
onderzoeken:  Jasper, Nicky en Julia erg bedankt voor jullie inzet en ik wens jullie 
veel succes met jullie eigen carrière!
Franka en Sjoukje, ook jullie heel erg bedankt voor de gezelligheid op de min 
twee! Bedankt voor de interesse die jullie altijd hadden, gezellig samen kletsen 
en lunchen. Met jullie was het toch minder stil op de min twee! Daarnaast wil 
ik jullie ook bedanken voor jullie medewerking tijdens de trainingsstudie in het 
sport medisch centrum ‘de eendracht’ van de Sint Maartenskliniek.
Mike Kattenbelt wil ik graag bedanken voor het verlenen van de trainingsrui-
mtes in het sport medisch centrum ‘de eendracht’ van de Sint Maartenskliniek. 
Hartelijk dank dat we altijd bij jullie terecht konden. 
Dewy, jij hebt al het voorwerk verricht voor de totstandkoming van dit 
proefschrift. Ik wil je heel erg bedanken voor de mooie dataset die jij destijds 
hebt verzameld! Het kan soms erg moeilijk zijn om in een dataset van een ander 
overzichtelijk dingen terug te vinden, maar het is me gelukt. Dat zegt wel wat 
over de nette manier waarop jij je werk op de afdeling reumatologie nagelaten 
hebt. 
Ook wil ik Wietske bedanken voor de prettige samenwerking in de eerste jar-
en van mijn onderzoek bij de afdeling reumatische ziekten. 
Graag wil ik het datacentrum, de VRC’s, alle reumatologen, het secretariaat en 
overige medewerkers van de afdeling reumatische ziekten van het Radboudumc 
bedanken voor de fijne samenwerking en alle hulp tijdens mijn onderzoeken!
Alle patiënten die deel hebben genomen aan mijn onderzoeken wil erg be-
danken. Zonder jullie had  dit proefschrift zeker niet tot stand kunnen komen. 
Hans, wat heeft dit proefschrift een mooie voor- en achterkant gekregen 
dankzij jouw werk! heel erg bedankt daarvoor!
Beste vriendinnen en vrienden uit Nijmegen en Brabant, bedankt voor de et-
entjes, verjaardagen, en gezellige afspraakjes die ik/wij met jullie heb(ben) naast 
het werk. Ik vind het erg leuk om de contacten met jullie te onderhouden.
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Lieve Bart en Patricia, Harm en Dorien, en mijn schoonfamilie. Ik wil jullie 
bedanken voor jullie interesse in mijn onderzoek, en de gezelligheid die we altijd 
met elkaar hebben. Ik hoop dat we nog vele jaren zo’n mooie familie zijn!
Lieve pap en mam, jullie zijn verantwoordelijk voor de basis van dit 
proefschrift. Ik ben jullie erg dankbaar voor al jullie goede zorgen, interesse’s en 
wijze raad in mijn leven. Alhoewel ik nu zelf een klein meisje heb, voel ik me bij 
jullie altijd nog het kleine meisje! Bedankt dat jullie altijd voor mij en ons klaar 
staan! ik hoop dat we samen nog heel veel jaren in goede gezondheid mogen 
doorbrengen! 
Lieve Jan, mijn proefschrift is af, nu het jouwe nog.  Ik had nooit gedacht dat 
jij mij achterna zou gaan. Meestal fiets ik achter jou aan. Bedankt voor jouw 
kritische en de vaak nog wat meer serieuzere blik op alles. Ik vind het erg leuk 
dat wij dezelfde interesses delen, eigenlijk al ons hele leven. Ik hoop heel oud te 
worden met jou! 
Lieve Floor, wat ben je toch een mooi meisje. Ik kan uren naar je kijken en 
met je spelen, jij kan net als papa en mama ook niet stilzitten. Jij hebt de laatste 
loodjes van dit proefschrift meegemaakt en vond het altijd gezellig bij mama in 
de buurt te zijn. Ik kijk uit naar alle mooie stapjes die jij gaat nemen de komende 
jaren! 
Sanne, juli 2015 
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Op 15 augustus 1986 is Sanne Annemarie Adriane van Dartel 
geboren te ’s-Hertogenbosch. Sanne is opgegroeid in het Braban-
tse Schijndel als jongste in een gezin met 3 kinderen. In 1998 
ging ze naar Gymnasium Beekvliet, te Sint-Michielsgestel. Tijdens 
haar jeugd is Sanne actief schaatster geweest en heeft ze in ver-
schillende gewestelijke selecties en baanselecties geschaatst. In 
2004 is ze geslaagd voor het gymnasium met de profielvakken 
natuur en gezondheid. In datzelfde jaar begon ze aan de opleid-
ing biomedische wetenschappen aan de Katholieke Universiteit Nijmegen (nu 
Radboudumc Nijmegen). In het kader van haar hoofdvak bewegingswetenschap-
pen heeft ze twee stages gelopen. Een eerste stage heeft ze gelopen bij de af-
deling bewegingswetenschappen aan de Vrije Universiteit te Amsterdam onder 
supervisie van Dr. A. Daffertshofer en Dr. J.J. de Koning.  Tijdens deze stage heeft 
ze onderzoek gedaan naar de  biomechanische en fysiologische factoren tijdens 
de overgang van zittend naar staand en van staand naar zittend fietsen op een 
stijgende en dalende helling. Haar tweede stage heeft ze gelopen bij de afdeling 
Fysiologie van het Radboudumc onder supervisie van Dr. T. Eijsvogels  en Prof. Dr. 
M.T.E. Hopman. Tijdens deze stage heeft ze een omvangrijk onderzoek uitgevo-
erd naar de thermofysiologische belasting, elektrolyten- en vochtbalans bij 250 
hardlopers die deelnamen aan de 7-heuvelenloop. In september 2009 behaalde 
Sanne haar Master of Science diploma. Na haar afstuderen heeft ze gewerkt als 
junior onderzoeker op de polikliniek orthopedie van het Radboudumc waarbij 
ze verantwoordelijk was voor de dataverzameling van het Klinisch Score Station. 
In september 2010 is ze als onderzoeker in opleiding begonnen binnen de af-
deling reumatische ziekten van het Radboudumc. Het eerste jaar van haar pro-
motieonderzoek heeft ze onderzoek gedaan bij patiënten met  reumatoïde artri-
tis naar het risico op ernstige infecties bij het gebruik van TNF blokkers. Tijdens 
de rest van haar opleidingstraject heeft ze onderzoek gedaan naar inspanning en 
vermoeidheid bij patiënten met reumatoïde artritis, waaruit dit proefschrift tot 
stand is gekomen. Haar promotieonderzoek werd begeleid door Prof. Dr. P.L.C.M. 
van Riel, Dr. J. Fransen, Dr. J.W.J. Repping-Wuts en Prof. Dr. G. Bleijenberg. Per 
half mei 2015 is Sanne werkzaam als coördinator zorginnovatie op de afdeling 
reumatologie in het Bernhoven ziekenhuis te Uden.  Sanne is getrouwd met Jan 
Rongen en samen hebben zij een dochter (Floor). 
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